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ABSTRACT OF THESIS

STABILIZATION OF EXTENDED DIFFUSE OPTICAL SPECTROSCOPY
MEASUREMENTS ON IN VIVO HUMAN SKELETAL MUSCLE DURING
DYNAMIC EXERCISE
This research investigates various applications of diffuse correlation spectroscopy
(DCS) on in-vivo human muscle tissue, both at rest and during dynamic exercise.
Previously suspected muscle tissue relative blood flow (rBF) baseline shift during
extended measurement with DCS and DCS-Near infrared spectroscopy (NIRS)
hybrid optical systems are verified, quantified, and resolved by redesign of optical
probe and alteration in optical probe attachment methodology during 40 minute
supine bed rest baseline measurements.
We then translate previously developed occlusion techniques, whereby rBF and
relative oxygen consumption rV̇O2 are calibrated to initial resting absolute values
by use of a venous occlusion (VO) and arterial occlusion (AO) protocol,
respectively, to the lower leg (gastrocnemius) and these blood flows are cross
validated at rest by strain gauge venous plethysmography (SGVP). Methods used
to continuously observe 0.5Hz, 30% maximum voluntary isometric contraction
(MVIC) plantar flexion exercise via dynamometer are adapted for our hybrid
DCS-Imagent diffuse optical flow-oximeter in the medial gastrocnemius. We
obtain healthy control muscle tissue hemodynamic profiles for key parameters
BF, V̇O2, oxygen saturation (StO2), deoxyhemoglobin, oxyhemoglobin, and total
hemoglobin concentrations ([Hb], [HbO2], and THC respectively), as well as
systemic mean arterial pressure (MAP) and pulse rate (PR), at rest, during
VO/AO, during dynamic exercise and during 15 minute recovery periods.
Next, we began investigation of muscle tissue hemodynamic disease states by
performing a feasibility pilot study using limited numbers of controls and

peripheral arterial disease (PAD) patients using the translated methods/techniques
to determine the ability of our technology to assess differences in these
populations.

KEYWORDS: Diffuse correlation spectroscopy; near-infrared spectroscopy;
blood flow; oxygen consumption rate; skeletal muscle;
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CHAPTER 1: INTRODUCTION AND BACKGROUND

1.1

Microvascular Hemodynamics and Metabolism in Muscle
The delivery of metabolic nutrients, oxygen, and removal of waste molecules

is of paramount importance for the maintenance of healthy tissue. As such, the
network of vessels, and the regulation of flow through those vessels have reached
a phenomenally sensitive status with respect to nervous, mechanical, and
metabolic stimulation. The small vessels (arterioles, capillaries, and venules) are
of a particular interest since it is in this part of the vasculature that large scale
exchange of O2 molecules occurs and where many of the regulatory systems take
their effect, as in the resistive elements of the pre-capillary arterioles. By
observing the hemodynamics, that is the blood flow, oxygenation status, and
tissue oxygen consumption rate parameters, of a tissue one can better understand
the extent to which the microvasculature is functioning and therefore how well the
homeostatic environment of the tissue is responding to functional demands. Of
particular interest is the study of the hemodynamics of the skeletal muscle.
Skeletal muscle, by virtue of both its sheer mass of body composition (40-50%
by mass)[1] and its necessity to everyday life, is a system whose function is
critical to maintaining a healthy, active lifestyle and whose function has been
strongly correlated to survival/life expectancy in various disease conditions[2].
Skeletal muscle is involved in every voluntary motion and in the function of the
muscles that operate the chest cavity during breathing. Disorders in skeletal
muscle function, whether by metabolic impairment, insufficient perfusion, or
contractile malfunction range in severity from decreased activity, pain and limited
1

mobility, such as in peripheral arterial disease (PAD), to loss of limb and tissue
ulcers, as experienced in diabetes and bedridden patients, to terminal wasting
diseases, as in muscular dystrophy and age related sarcopenia[2]. It is estimated
that about 8 million cases of PAD currently exist in the U.S. alone and that 1220% of people over the age of 60 suffer from the disease[3]. These numbers are
expected to swell with the increasingly aged population and the highly prevalent
risk factors (smoking, obesity, diabetes, and high cholesterol) that contribute to
the disease. The costs associated with patient care for PAD and other muscle
wasting diseases will likewise rise substantially[4].
In addition to the various disease states which affect muscle, the function of
muscle is of great interest to sports and exercise medicine. It can be difficult to
assess functionality in terms other than gross power output or morphology. The
perfusion and oxygenation of muscle tissue has direct implications on the ability
of that muscle to perform[5]. Different activities and types of exercise/athletics
exert different forms of hemodynamic response and these can be characterized to
improve the responsiveness of a training regimen or to tailor a training toward a
specific functional state (high endurance via sustained oxygen saturation vs.
hypertrophic increases in muscle mass for power lifting)[6].
Despite the imminent importance of the skeletal muscle system and the
volume of disease populations suffering from muscular disorders, there are
relatively few ways to noninvasively assess the performance of muscle tissue in
vivo, especially with respect to local blood perfusion and tissue oxygenation[7].

2

1.2

Tissue Blood Oxygenation Measurement
Traditional measurement techniques for determining the oxygenation of

blood/tissue and thus the metabolic activity of the tissue relied on indirect
methods such as Douglas bag spirometry or respiratory gas analysis, which
measure oxygen concentration decreases/carbon dioxide increases in expired
air[8]. This technique only measured the global metabolic rate and would only be
used to indicate net gas exchange at time points for only as many gas bags as are
feasibly available to be implemented as a single measurement may be taken with
a particular bag and thus serial measurements require multiple bags, thus greatly
limiting sampling rates and specificity of the measurement. Spirometry is then
unable to localize oxygen consumption rate measurements in active muscles and
cannot then be used in a diagnostic or evaluative manner for specific organ
systems. More recently, blood oxygen and chemical analysis have been used to
sample tissue metabolism but this involves invasive catheterization of the vessels
and lacks an ability to make continuous measurements[9]. These techniques also
share the weakness of being unable to localize the oxygen consumption rate to a
specific muscle compartment since the vessels catheterized are typically large
arteries and veins at opposing ends of the limb. Functional MRI (fMRI) has also
been used to track changes in blood oxygenation in the tissue
microvasculature[10]. The functional MRI imaging allows continuous and
noninvasive monitoring of tissue oxygenation with high spatial resolution in deep
tissues. Temporal resolution of such measurements is limited with BOLD (blood
oxygen level dependent) measurements requiring as much as 12-18 seconds to
3

produce a measurement [11, 12]. fMRI and other radio-imaging techniques will
be discussed further in Chapter 1.4 as they are also used to assess tissue blood
flow. Optical methods of measuring local tissue oxygenation have been
developed that use near infrared (NIR) light to measure the concentration of
oxygen binding chromophores; the specifics of which are discussed more
thoroughly in Chapter 1.3.
1.3

Near-infrared Spectroscopy (NIRS) for Tissue Blood Oxygenation
Measurement
Over the last few decades, near-infrared (NIR) tissue oximetry has gained

wide acceptance and been implemented in a broad range of applications, both
clinically and in academia[12-20]. The noninvasive and exquisitely sensitive
detection of tissue oxygenation, using relatively inexpensive and portable
equipment with fast acquisition times has revolutionized deep tissue metabolic
observation. NIR is made possible by the existence of a low absorbance band
(700 to 900 nm) of light in tissue. Within this band, the dominant absorbers in
tissue are oxy-hemoglobin, deoxy-hemoglobin, fat, and water (Figure 1).
Of the aforementioned absorbers, the primary two to change dynamically are
the oxygen binding blood metalloproteins: oxy- and deoxy-hemoglobin, denoted
HbO2 and Hb respectively. Thus the majority of light absorption changes in this
band are attributable to the blood chromophores and these two are clearly
spectrally distinguishable (Figure 1)[15, 21].
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Figure 1. Absorption Spectra and the NIR Optical Window
The aborbances of HbO2 and Hb are very similar at 800 nm thus this wavelength should be
avoided when using NIR light to detect tissue absorption. Other absorbers such as water and lipid
(fat) have minimal absorption between 700 and 900 nm thus sources in this range should have
maximal penetration depths.

As NIR photons move through tissue, they are scattered at a much greater rate
than they are absorbed creating a diffusive profile of movement through the tissue
medium in which some photons are eventually diffused back to the tissue surface
interface. This process is very complex and has been given a thorough treatment
elsewhere, readers are invited to examine literature[15, 22]. The degree to which
a media will absorb light is characterized by its absorption coefficient (μa), and
the degree to which photons tend to scatter is likewise characterized by its
reduced scattering coefficient (μs’), both with the unit of per centimeter (cm-1). In
NIRS it has been established that by illuminating tissue with two or more
wavelengths of light in the NIR optical window band, measuring the changes in
detected light intensity a certain distance away from the source, and knowing the
5

extinction coefficients of the involved absorbers, the changes in absorber
concentration can be quantified[12, 15, 17, 22-24]. This relationship, including a
modification that adjusts for multiple scattering events, is known as the modified
Beer-Lambert Law[15, 21] and will be discussed in detail later. The use of
different source illumination modalities, as well as the detection of intensity
changes at multiple source-detector (S-D) separations allows for the calculation of
absolute absorbers’ concentrations (e.g., [HbO2] and [Hb]) in tissue[25]). These
absolute measurements may then be combined to derive total hemoglobin
concentration (THC= [HbO2] + [Hb]), and tissue blood oxygen saturation (StO2 =
[HbO2]/THC ×100%).
The three categories of NIR oximeter are continuous wave (CW), frequency
domain (FD), and time domain (TD) systems whose categorization can be made
by illumination pattern (Figure 2).

6

Figure 2. NIRS Illumination Modalities
The CW system (panel a) employs a continuous source illumination in which the intensity changes
can be used to calculate absorber concentration changes. FD system (panel b) modulates the line
with sine waves and the changes in signal amplitude and phase allow for calculation of absolute μa
and μs. These are then used to calculate absolute concentrations of absorber molecules[24]. The
TD system (panel c) injects a defined short pulse of light into the tissue and detects the change in
amplitude of the pulse as well as its shape. These two qualities can be used to determine the
values of the absolute chromophore concentrations[19].

CW oximeter is the simplest to operate and analyze, as well as the most
inexpensive, but can only yield relative changes in hemoglobin concentrations.
The other two systems can produce absolute absorber concentrations but are more
expensive with an additional layer of data analysis. The TD system, requiring a
larger amount of time to measure intensity pulse width, thus has a lower sampling
time than the other two systems. Our lab makes use of a commercial FD-NIRS
oximeter (Imagent, ISS Inc., IL), whose details will be discussed in Chapter 2.1,
to detect absolute values of [Hb] and [HbO2] as it has the capability of detecting
absolute tissue oxygenation with temporal resolutions ranging from 0.5 to 100 Hz,
depending on noise tolerances.
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1.4

Tissue Blood Flow Measurements
Using NIRS to measure blood flow is a relatively recent addition to the

repertoire of noninvasive optical measurements. Previous flow measurements
relied on invasive catheterization of the large vessels with pressure transducers.
In addition to the invasiveness of this technique, it limits measurement to the
vessels smaller than the catheter. More advanced local clearance techniques such
as 133-Xe washouts and Indocyanine green dyes (ICG) make use of indicator
dyes and their clearance rates to quantify blood flow through the microvascular
beds. However, these techniques are still invasive and some may also employ
radioactive materials. Furthermore, due to recycling of the dye, continuous or
quickly repeated measurements are impossible[26].
Noninvasive measurements of flow historically include strain gauge venous
plethysmography (SGVP), a technique in which pressure in excess of diastolic
(venous return) pressure is applied to the limb, preventing blood from leaving the
compartment. A strain gauge is used to measure the rate of change in limb
circumference and thereby calculate the volume of inflowing blood. This
measurement is, by its nature, disturbing to flow and cannot be performed in rapid
succession[12, 26, 27]. This measurement method is also only useful for
assessing whole limb flow and so cannot be used to distinguish local working
muscle group blood flow from passive muscle flow. SGVP will be discussed
more thoroughly in Chapter 4 and the Appendix where it was used as part of a
protocol, for comparison/validation purposes.
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More advanced noninvasive flowmetry has been developed using magnetic
imaging techniques or PET. fMRI and PET stand out as effective methods for
assessing the combined parameters of tissue oxygenation, blood flow, or
phosphate metabolites. Temporal resolution for these is fair (~0.1 Hz for arterial
spin labeled fMRI and 0.025 Hz for PET), though lacking when compared to
other techniques such as Doppler Ultrasound, Laser Doppler, and NIR diffuse
correlation spectroscopy (DCS)[11, 28]. The spatial resolution to both is fine,
ranging from 100-250 μm for fMRI and 1.5 mm for PET[11, 29]. Whether the
temporal sensitivity loss is worth the spatial gain is dependent on the purpose of
the study. The major disadvantages of fMRI and related imaging technologies
have always been the cost, the degree of difficulty in analysis of acquired signals,
and the requirement that patients be confined to an MRI tube which severely
limits the potential exercising applications of the technology. Additionally, PET
is still reliant on the use of radioactive elements. Some of these methods, ASL
MRI at least, may have limited use in low blood flow scenarios which makes it
non optimal for assessing resting or recovery values of blood flow[28].
Doppler ultrasound (DU) has proven to be a reliable technique for assessing
large vessel flow with a high temporal resolution and deep tissue penetration. As
its name implies, ultrasound relies of the insonation of the tissue with high
frequency sound waves[26]. However, the technology is limited in exercise
protocols by the necessity of maintaining a set insonation angle and good
insonator/receiver contact. The major weakness inherent to DU flowmetry is in
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that only larger blood vessels may be observed. This means that only the supply
vessel flow and not the exchange vessel flows can be observed.
Overall, each of these flowmetries has advantages or disadvantages in terms of
cost, sensitivity, or ease of operation. However, none of them meet the demand of
making noninvasive, continuous and dynamic measurements, with high
sensitivity, high temporal resolution, in deep tissue microvasculature. Recently
developed NIR DCS-based technologies showed the potential to meet these
requirements (see Chapter 1.5)[12, 15, 30-32].
1.5
NIR Diffuse Correlation Spectroscopy (DCS) for Microvascular Blood
Flow Measurement

NIR Diffuse correlation spectroscopy (DCS) is a method of assessing
microvascular perfusion that has been developed over the last twenty years. DCS
incorporates the same NIR light band as NIRS but applies this photon
illumination and detection scheme to observe a distinctly different system.
Instead of observing chromophore concentrations, this system monitors light
speckle fluctuation at the tissue surface. Speckles are discrete regions of photon
intensity generated by the effects of moving scatterers in highly scattering media
on photons traveling through it, and which can be produced by illuminating tissue
with a long coherence CW laser[15, 22]. The presence of scattering bodies under
motion, which for biological tissues is predominantly limited to erythrocytes in
the blood, causes these speckles to fluctuate rapidly. The multiple scattering of
photons by moving bodies, each of which imparts a random vector and phase shift
to the photons producing, when summed, a temporally fluctuating interference
10

pattern at the interface[15, 22]. By measuring the intensity changes of a single
speckle using a single mode optical fiber connected to a single photon counting
photodetector and correlating them using an autocorrelator, these changes can be
quantified to assess the average flow of moving scatterers (red blood cells) within
the photon path and used as an index of blood flow. By normalizing the blood
flow index to its initial resting baseline value, the relative blood flow (rBF) can be
obtained[15, 20, 33]. The theoretical specifics of how speckle intensity
fluctuations are used to calculate blood flow index and rBF will be left to the
discussion of methods in Chapter 2.
The advantage of this system is that it possesses a high temporal resolution (up
to 100 Hz), a reliable tissue penetration depth of up to ~1.5 cm (deep enough to
observe superficial muscle), noninvasiveness, portability, and low running costs
of optical spectroscopy[34]. The ability to noninvasively measure microvascular
blood flow with high temporal resolution is unique to the DCS and makes it of
particular use in clinical application to evaluating deep tissue perfusion. This
technology has been validated against several accepted techniques including XeCT, arterial-spin-labeled MRI, Doppler ultrasound, power Doppler ultrasound,
and fluorescent microspheres[16, 28, 35-40]. The tissues observed, as previously
mentioned, also range broadly and include human/mouse brains, head/neck
tumors, breast, and skeletal muscle[16, 28, 31, 36-43]. The recent innovation of a
novel gating algorithm in our laboratory has allowed the use of DCS with
minimal motion artifacts, such as those prevalent during muscle contractions in
previous studies[16, 31, 44]. Also, a commercial tissue oximeter has been
11

employed in conjunction with DCS to create a hybrid diffuse optical flowoximeter (see Chapter 1.6)[8, 15, 31, 32].
1.6
Hybrid Diffuse Optical Spectroscopies for Measurements of Both
Tissue Blood Flow and Oxygenation

In the past our lab had developed two types of hybrid instruments for
simultaneous microvascular blood flow and oxygenation measurements: a dualwavelength DCS (CW)[45-52] flow-oximeter and a combined DCS/FD-NIRS
(Imagent) flow-oximeter[31, 32, 41, 53]. By using a second wavelength long
coherence source laser and alternately illuminating the tissue with 2 wavelengths
it is possible to simultaneously collect both relative changes in tissue oxygenation
(Δ[Hb], Δ[HbO2], and ΔTHC), as discussed in Chapter 1.3, and rBF as discussed
in Chapter 1.5[15]. CW-DCS flow-oximetry is relatively inexpensive and allows
for continuous quantification of the real time changes in microvascular
hemodynamics with a locality, sensitivity, and temporal resolution unavailable to
other systems.
Combination of an FD-NIRS and DCS requires the integration of two separate
sets of hardware and their associated operating software. This additional layer of
complexity is largely offset by the gain of absolute tissue absorption and reduced
scattering coefficients, which were previously assumed for the sake of DCS
measurements. Most importantly, this system has the advantage of determining
[HbO2], [Hb], THC, and StO2 in absolute units. These are necessary to perform
occlusion calibrations for initial values of absolute tissue blood flow (BF) in units
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of ml blood*100ml tissue-1*min-1 and the derived oxygen consumption rate (V̇O2)
in units of mlO2*100g-1*min-1[31, 53].
This recently adopted hybrid FD-NIRS/DCS optical system, combined with
finger plethysmography measurements of mean arterial pressure (MAP) and pulse
rate, allows for the simultaneous collection of a suite of hemodynamic parameters
which include relative/absolute blood flow (rBF/BF), relative/absolute oxygen
consumption rate (rV̇O2/V̇O2), [Hb], [HbO2], THC, StO2, MAP, and pulse rate.
All of these measurements are made continuously, noninvasively, and rapidly
making hybrid diffuse optical measurements of unique benefit in evaluating tissue
microvascular hemodynamics and metabolism.
1.7

Baseline Stability of DCS Contact Blood Flow Measurement
In previous studies performed on muscle tissue, we noted that blood flow

index (αDB) exhibited an unexpected increase during prolonged measurements.
Previous investigations revealed that no such trend in blood flow was observed
during contact probe cerebral hemodynamics measurements[41] nor were they
observed during preliminary measurements on gastrocnemius tissue using a
noncontact probe (unpublished data). This eliminates immediately DCS hardware
drift and effects of the source on the tissue since both the noncontact and contact
probe use the same instrument. Given that muscle tissue and cerebral tissue have
vastly different conditions (fixed skull geometry for the cerebral tissue, pliable
muscle tissue with possible contractile motion/geometry artifact in the muscle,
different autoregulatory innervations, etc.), it is possible that the tissues might
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have differential responses associated with the measurement. We thus hypothesize
that only factors related to the unique combination of muscle tissue and use of
contact probe to measure it can be attributed to the baseline BF shift. Details for
solving the problem of baseline BF shift can be found in Chapter 3.
1.8
Measurement of Hemodynamic and Metabolic Profiles During
Exercise in Gastrocnemius Muscle

Eventually our research aims to examine patient populations which have
diseases of muscle hemodynamics and metabolism. Many of these diseases
preferentially affect the lower limbs. This study then aimed at applying absolute
calibration of continuous, relative, optical measurements during exercise to the
lower limb (gastrocnemius). Calibration of relative measurements consists of
performing a series of occlusions in order to obtain initial resting baseline values
for BF and V̇O2 that have been met with success in previous studies by this
lab[32]. For the purposes of transferring the dynamic measurement methods in
forearm, as described by Gurley et al [32] during handgrip exercise, to the lower
limb, we decided to employ a plantar flexion exercise protocol with a fixed
percentage (30%) maximum voluntary isometric contraction (MVIC) in healthy
subjects. This protocol would allow us to establish a complete
hemodynamic/metabolic profile of typical responses to exercise in the lower limb.
The protocol, detailed in Chapter 4.1 and 4.2, closely mirrored a study performed
by Bauer et. al., giving this protocol some precedent in physiological
literature[54]. Strain gauge venous occlusions were used to concurrently measure
absolute limb BF in the gastrocnemius at resting baseline and post exercise in
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order to assess the validity of our BF calibration and to examine the whole limb
BF response to exercise in comparison to local tissue.
1.9

Pilot Study on Peripheral Arterial Disease (PAD)
Our major purpose in transferring continuous absolute measurement methods

applied previously in the forearm to the gastrocnemius is to initiate investigation
into the hemodynamic effects of PAD on lower limb muscles. PAD is a vascular
insufficiency in the lower limbs that results in an ever increasing difficulty in
supplying the tissue with oxygen, particularly noticed during every day events
such as walking or working on ones feet. The disease is commonly found in
patients who suffer from hypertension, diabetes mellitus, atherosclerosis, and
smokers[55]. As the vascular integrity of the patients deteriorates, the symptoms
of PAD worsen until the ischemia becomes severe enough to induce necrosis. In
this case the lower limbs, most often starting at the feet, begin to ulcerate
producing wounds prone to infection and highly resistant to healing[3, 55-57].
The muscle locality and compromise of both flow and oxygenation due to this
disorder seemingly make hybrid flow-oximetry an ideal system with which to
observe such a disorder.
1.10

Thesis Organization

This thesis is organized as follows. Chapter 2 introduces the methods and
theory behind NIRS oximetry and DCS flowmetry, which are the predominant
systems employed in this work. The methods for calibrating relative blood flow
using venous occlusion and relative oxygen consumption using arterial occlusion
15

are also described. Lastly a brief discussion of data processing and statistical
methods is made.
Blood flow measurement stability on in-vivo muscle must first be established
to confirm/remediate possible baseline blood flow elevations. Thus a series of
baseline DCS contact measurements are made to assess the long term stability of
in-vivo relative flow, which are presented in Chapter 3.
The diffuse optical techniques used to calibrate local absolute baseline values
for blood flow and oxygen consumption rate and for continuous monitoring
related hemodynamic responses during exercise have thus far only been applied to
examine hemodynamics of the forearm flexor muscles. This muscle group is of
limited interest in the investigation of some perfusion disorders in lower limb and
the broadening of ranges of muscle groups which we may assess during exercise
is important for bringing this technology to clinical relevance. Chapter 4 then
describes a study performed to translate absolute calibration of relative
hemodynamics and continuous exercise methods to the gastrocnemius.
The ultimate goal of this research is to use hybrid diffuse optics clinically,
applying them to patient populations (e.g., PAD) for eventual diagnoses and
treatment monitoring. To this end, the final study of this thesis, Chapter 5, is a
small pilot study designed to determine whether or not our methods and
instrumentation is feasible to be used in patients with PAD at rest and during
exercise.
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At the end, Chapter 6 discusses the difficulties and methodological
considerations that were involved with each of the studies herein, and summarizes
results, conclusions and future perspectives.
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CHAPTER 2: DIFFUSE OPTICAL METHODS, INSTRUMENTATION
AND DATA PROCESSING

This chapter is devoted to discussion of the theories of diffuse optical
flowmetry and oximetry and instrumentation used to make microvascular
hemodynamic/metabolic measurement (Chapter 2.1 and 2.2). It also introduces
the methodology and theory of using venous and arterial occlusions to measure
absolute tissue blood flow and oxygen consumption rate respectively (Chapter 2.3
and 2.4). These values are used to calibrate relative optical measurements. Lastly
a brief discussion of gating algorithm to reduce motion artifacts and data analysis
methods will be made (Chapter 2.5).
2.1

FD-NIRS Oximetry
Absolute tissue oxygenation measurements are made using a commercial 4-

wavelength FD-NIRS instrument (Imagent, ISS Inc., IL). The Imagent spatially
resolved spectroscopy employs four, 110 MHz modulated sources at 690, 750,
780 and 830 nm to probe tissue absorbance. The source light is injected via
multimode source fiber optic cables (diameter = 400 μm) at 4 S-D separations
(2.0, 2.5, 3.0 and 3.5 cm) for all wavelengths. After diffusing through the tissue,
the light is collected via large diameter multimode fibers (diameter = 2.5 mm) and
detected by a photomultiplier tube (PMT) which converts the detected photons
into a voltage signal.
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Figure 3. Probe Geometry and Photon Path
The path of photon diffusion is characterized by an inverted “banana” shape region from the
source to the detector, distance denoted ρ. Note the random scatter vectors and semi-infinite
geometry. Semi infinite refers to the existence of a single flat boundary condition in which
photons only undergo transitional effects at the source/detector interface. Additionally assumed is
the homogeneity of this medium, which is a somewhat generous approximation of tissue.

Since the light is frequency modulated, the detected intensity has a modulated
light amplitude (AC signal), an average light intensity (DC signal), and a
difference in time or phase (φ).
The method of calculating the absolute scattering and absorbing coefficients of
the tissue are based upon a photon diffusion equation [15, 30]. The equation, and
details related to its derivation and solution may be found in the immediately
preceding citations. The results are that a linear relationship exists between the
natural log of the AC signal, the natural log of the DC signal, and φ at different SD separations (r). These linear relations can be fit and their slopes (denoted Sdc,
Sac, Sφ) can be used to calculate the absolute μa and μs’ via the following
equations[58]:

(

)

(

)

ln dc ⋅ r 2 = rSdc μ a , μ s + In dc (D, K dc )
'
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Here, μa is absorption coefficient, μs’ is reduced scattering coefficient, D is the
photon diffusion constant (υ/3μs’), υ is the speed of light in the media, r is the S-D
separation, ω is the modulation frequency, and Kx represents constants associated
with the illumination/detection hardware. Specifically, these constants depend on
detector sensitivity and modulation frequency (KAC), source intensity (KDC), and
phase differences (Kφ) between source and external phase contributions (outside
noise). To reduce noise from the environment and since only two slopes are
required to calculate the optical properties (μa and μs’) at each wavelength, it is
preferable to use the ac and phase slopes[58].
The absorption coefficient can be related to chromophore contributions at a
particular wavelength wherein the total absorbance is a sum of contributing
absorbers 1 to i[15]:
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μ a (λ ) = ∑ ε i (λ )[i]

(7)

i

This equation indicates that μa(λ) is dependent on the extinction coefficient (εi)
of the contributing chromophores multiplied by their concentrations [i]. By
knowing the μa(λ) at two wavelengths (from the slope acquisitions Eq(1) to Eq(6))
and the extinction coefficients for the two chromophores at both wavelengths, the
two unknown concentrations of absorbers ([Hb] and [HbO2]) can be
reconstructed.
Examination of in-vivo measurements of tissue oxygenation found that the
phase components of spatially resolved spectroscopy at multiple separations
introduced noise that was confounding to the precise short time changes in
hemoglobin concentrations necessary for calibration of BF[20]. To retain the
advantage of FD-NIRS absolute measurements but eliminate this noise, we
obtained absolute baseline measurements of [Hb], [HbO2], THC, and StO2 using
the spatially resolved spectroscopy capability during an initial baseline. These
absolute baselines were used to calibrate the relative hemoglobin concentrations
Δ[Hb], Δ[HbO2], and ΔTHC obtained using modified Beer-Lambert calculations
of single separation (2.5 cm) detected intensities from 690 and 830 nm
sources[15, 20]. Specifically, the calculation of relative chromophore
concentrations involves the following procedure:
First the differential pathlength factor (DPF) or distance traveled by photons in
a scattering media with a fixed S-D separation must be calculated. It should be
noted that the DPF listed here is an empirically determined value which is based
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on the relationship between changes in absorption coefficient, reduced scattering
coefficient, and S-D separation (r):

𝐷𝑃𝐹(𝜆) =

�3µ's (λ)�3µa (λ)µ's (λ)∙r

(8)

2�3µa (λ)�3µa (λ)µ's (λ)+1∙r

The advantage here of using a spatially resolved FD-NIRS instrument is that
the baseline μs’ and μa is measured directly for the calculation of DPF.
Next, “A (λ)” refers to the optical density or the logarithmic change in detected
intensity due to changes in absorber concentration compared to the initial baseline
intensity and is calculated by[15]:
A(λ ) = log

I
= ∆µ a (λ ) DPF (λ )r
I0

(9)

By measuring the optical density (A) at two wavelengths, substituting Eq. 7 for
the changes in absorption coefficient concentration, and knowing the extinction
coefficients of the absorbers it is possible to solve for the changes in the two
chromophore concentrations as shown here:

A(λ1 )
A(λ2 )
−
ε
λ
(
)
1
HbO
2
2
DPF (λ1 )
DPF (λ2 )
∆[ Hb] =
ε Hb (λ1 )ε HbO2 (λ2 ) − ε Hb (λ2 )ε HbO2 (λ1 )r

ε HbO (λ2 )

A(λ2 )
A(λ1 )
− ε HbO2 (λ2 )
DPF (λ2 )
DPF (λ1 )
∆[ HbO2 ] =
ε Hb (λ1 )ε HbO2 (λ2 ) − ε Hb (λ2 )ε HbO2 (λ1 )r

(10)

ε HbO (λ1 )
2
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(11)

Relative changes in hemoglobin concentration (Eq. 10 and 11) are calibrated to
absolute units by addition of absolute baseline values of the respective
chromophore concentrations obtained by the spatially resolved spectroscopy
method.
2.2

Diffuse Correlation Spectroscopy (DCS) Flowmetry
DCS measurements of a microvascular flow index are described in detail in

many previous publications[22, 35] and so will be discussed here more briefly.
The technology has its roots in the physical modeling of light correlation
dynamics through turbid media. By illuminating the tissue with a long coherence,
CW-NIR source (785, 830, or 854 nm, Crystalaser Inc. NV, USA) a temporally
varying speckle pattern may be generated at the tissue surface. This speckle
fluctuation is detected by a single-mode fiber connected to a single photon
counting avalanche photodiode (APD, PerkinElmer Inc., Canada). By using 4
bundled fibers bundled into a single tip, 4 channels of speckle intensity data can
be collected simultaneously from a single location. The data are sent to a 4channel autocorrelator board (Correlator.com, NJ, USA), producing normalized
intensity autocorrelation functions (g2), which are averaged to improve signal-tonoise ratio (SNR). The intensity autocorrelation function is then related to the
normalized electric field autocorrelation function (g1) through the Siegart relation:

g 2 (r⃑, 𝜏) = 1 + 𝛽|𝑔1 (r⃑, 𝜏)|2

(12)

where g2, again, is the normalized intensity autocorrelation function, g1 is the
normalized electric field autocorrelation function, τ is the delay time, ⃑r is the

position vector associated with the photon path, and β is the coherence factor. β is
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related to the coherence length, optical system stability, and is inversely
proportional to the number of speckles observed[15, 20, 30, 33, 59]. The reason
for introduction of the normalized electric field autocorrelation function g1, is that
the relation of dynamic scatterer motions (erythrocytes) in turbid media (tissues)
to correlation diffusion are actually derived in terms of the un-normalized electric
field autocorrelation function G1. For a thorough treatment of the derivation and
solution of the equations that model these processes the reader is encouraged to
attend the following sources[15, 22, 30]. To abbreviate this more rigorous
process, it will do here to say that the electric field correlation dynamics, from a
CW-long coherence source, in a homogenous turbid medium is of the following
form[15, 22]:
1

�𝐷∇2 − 𝑣𝜇𝑎 − 3 𝑣𝜇𝑠 ′𝑘0 𝛼〈∆r 2 (𝜏)〉� G1 (r⃑,τ)= − 𝑣𝑆(r⃑)

(13

Equation 13 is the so-called correlation diffusion equation where α is the ratio
of dynamic to total (static + dynamic) scatterers, k0 = 2πn/λ is the photon wave
number (n is refractive index), and 𝑆(r⃑) is the source light distribution term[15,
30]. Critical to this equation is the term α〈∆r2 (τ)〉 (α multiplied by the mean

squared displacement of dynamic scatterers), which introduces the relation of
photon correlation decay to the ratio and mean squared displacement of moving
scatterers. It should be noted that α and 〈∆r2 (τ)〉 are inseparable in this treatment.

The mean squared displacement of moving scatterers is parameterized by a
diffusion model via:

〈∆r 2 (𝜏)〉 = 6DB (τ)

(14)
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Of particular importance is the relationship between 〈∆r 2 (𝜏)〉 and the

Brownian diffusion coefficient DB given by Eq.14. Flow through capillary
networks is tortuous and, in a spatial average, without specific direction, thus
movement of erythrocytes can be approximated by diffusion. For more
discussion of DB and the justifications for its use in biological tissue see
references[22, 45]. After substitution, a blood flow index αDB can be obtained.
Equation 14 is supported by experimental fit to diffuse models and Monte Carlo
simulation[15, 30, 45, 60]. The advantage of this model of autocorrelation
function diffusion in tissue is that the mathematics of the equation is well defined,
similar to the photon diffusion equation[15, 30]. For a fixed semi-infinite
geometry (See Figure 3) alongside a few assumptions, this equation can be solved
to generate an analytical solution[22, 35]:

𝐺1 (𝜌, 𝜏) =

𝑣𝑆0

𝑒 −𝑘(𝜏)r1

�
4𝜋𝐷

r1

−

𝑒 −𝑘(𝜏)r2
r2

�

(15)

which can then be normalized to the form
 e − k (τ ) r1 e − k (τ ) r2
−
g1 (r ,τ ) = 
r2
 r1

  e − k0 r1 e − k0 r2
 • 
−
r2
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−1

(16)

2
2
2
2
'
where r1 = ρ + zo , r2 = ρ + ( z0 + 2 zb ) , k0 = 3µ a µ s , z0 = 1/(μs’+ μa ) ,

z b = 2(1 + Reff ) / 3μ s (1 − Reff ) , Reff = 1.440n-2 + 0.710n-1 + 0.0636n + 0.668, n =
'

1.33 for tissues, and k (τ ) 2 = 3µ s ' µ a + µ s '2 k0 6αDB . The position vectors r1 and
2

r2 refer to the S-D geometry with ρ being the S-D separation and values of z being
related to the boundary condition of light moving through mismatched indices of
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air and tissue (Reff) at the surface interface of the source ([0, 0, 0]) and detector
([ρ, 0, 0]). For a given measurement of g2, and the subsequent calculation of g1,
the only unknowns in this solution are the optical properties of the medium and
the flow index αDB [cm2/s]. This unit is not typical of flow and results from the
spatial averaging of moving scatterers within the tissue volume and the sourcedetector geometry[15, 30].
By assuming or measuring the optical properties of the media (e.g., using
Imagent), the solution listed in Eq. 15 can be normalized and then employed to
calculate flow index αDB by least mean square error fitting of the measured g1
curve with the modeling g1 curve as described by Eq. 16. The process is
diagramed in Figure 4. While each intensity autocorrelation curve only takes a
few fractions of a second to obtain, many of these correlation curves are averaged
to reach adequate SNR. In effect these correlation averaging times are the
limiting factor for DCS temporal sampling rates. In this study we used ~300 ms to
produce a single blood flow index. This index can then be used to calculate
relative blood flow (rBF) by normalizing αDB(t) to a passive, unperturbed
baseline via:

rBF = [αDB(t)/αDB(t = 0)] ×100%

(17)

This relative measure of blood flow can be calibrated through a well accepted
protocol combining the measurement of THC increases during a venous occlusion
protocol as will be discussed in detail in Chapter 2.3[13, 14, 20, 61].
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Figure 4. Data Collection and Analysis Regime for DCS
Detected speckle intensities are collected and autocorrelated to produce intensity autocorrelation
curves g2. This data is then related to the electric field autocorrelation function and fitted against a
model solution to compute the flow index αDB. Analysis is performed via MATLAB code and
the fitting between calculated G1 and theoretical solution G1 curves is done by fminsearch function
for multiparameter least mean squares. The initial value for αDB is set as 1E-8 and then the values
of αDB are varied until a minimum error is reached within a certain number of iterations. This
method can be used for simultaneous fitting of coherence factor β and αDB since the two
parameters have no cross talk, as investigated in detail elsewhere[62].
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2.3

Calibration of Relative Blood Flow (rBF)

As has been mentioned earlier, the result of DCS flow index measurements
requires a calibration to provide an absolute flow value in standard unit
(ml/100ml/min). This calibration is provided by the well accepted method of
performing a venous occlusion (VO) and calculating the arterial inflow via a
change in blood volume within the compartment[14, 26, 27, 55, 61]. VO is
accomplished by use of a pressure cuff acting as a tourniquet[13, 14, 61].
Inflating the cuff to super-diastolic pressures of 50-60 mmHg results in the
inability of blood to leave the venous compartment. Strain gauge
plethysmography, as earlier described, measures gross change in limb volume
globally. NIRS however measures the change of THC (proportional to blood
volume) for a discrete volume of tissue[14, 26, 27, 63, 64]. The equation to
calculate BF is given as:

BF =

1 d [THC ]
⋅
dt
C

(18)

Thus the NIRS measurement during VO provides a rate of change for the
concentration of hemoglobin in μM/kg/min, which can then be converted to blood
flow by the application of Eq. 18. The example measurement of THC using
Imagent and THC fitting during multiple VOs is illustrated below in Figure 5.
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Figure 5. Venous Occlusion Protocol and THC Slope Fitting
Each occlusion was performed for 10 seconds as the linear increase in THC is transient. This
slope was fitted using MATLAB polyfit function for the THC (note that THC and THb are
interchangeable) between the two marked (vertical line) data points. The average of these three
slope values was used to calibrate rBF measurements.

The conversion to ml blood/100ml/min is performed by dividing concentration
by the concentration of hemoglobin in blood (14.1 g/dL) and multiplying by the
molecular weight of hemoglobin (64.458 g/mol)[17, 31]. You then perform some
minor unit conversions to take into account the μMol to mol ratio (divide by 106)
and convert to per minutes (multiply by 60) along with converting from deciliters
to 100ml and g/kg to resolve the g/kg muscle ratio (multiply by 10,000). Nioka et
al provides an abbreviated approximation of 1 μM/kg/sec to 3 ml/100ml
tissue/min[17]. This approximation is very close to Gurley’s calculated value of
2.74 ml blood/100ml tissue/min per 1 μM/kg/sec [20].
2.4

Calibration of Relative oxygen Consumption Rate (rV̇O2)
In addition to flow, oxygen consumption rate is one of the metabolic

parameters of greatest interest to physiologists and clinicians trying to determine
the health/level of activity of tissue. The metabolic activity of a tissue can be
used to diagnose its functional condition and to discern a pathological loss of said
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function. Derivation of oxygen consumption rate requires both the arteriovenous
difference in O2 concentration and blood flow information of the tissue via the
Fick principle[31, 45, 65]:

V̇O2 = BF × ([O2]a - [O2]v)

(19)

The arterial blood has an assumed constant oxygen saturation (SaO2) of >98%.
This blood is then understood to deliver some amount of oxygen into the tissue
and then mixed with the blood occupying the venous compartment. StO2 may be
measured by NIRS and from these we can calculate the oxygen extraction fraction
(OEF) as the arteriovenous difference comparing tissue StO2 during arterial
occlusion to the initial SaO2:

OEF = ([O2]a -[O2]v)/[O2]a

(20)

This equation can then be considered in terms of StO2 saturation, which
should decrease due to oxygen consumption during arterial occlusion.

OEF = (SaO2 - StO2)/(γ × SaO2)

(21)

By approximating > 98% SaO2 as 1 and the term γ (the percentage of blood
volume contained by the venous compartment) as a constant, we may calculate
the relative OEF as

rOEF = (1 - StO2)/(1 - StO2baseline)

(22)

The relative oxygen consumption rate may then be calculated using only
optical information obtained by the hybrid optical instrument:
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rV̇O2 = rBF × rOEF

(23)

This relative value is useful but the absolute values are desired, as is the case
for blood flow, in order to compare the potentially meaningful baseline,
maximum, and minimum values to other measurements obtained using different
equipment, or to determine physiologically relevant differences between
patient/subject populations.
The calibration of absolute V̇O2, similarly to that of BF, is done using a brief
occlusion of the limb. In the case of V̇O2 however, it is necessary to increase the
pressure of occlusion to super-systolic (at least systolic + 50 mmHg) levels for a
total arterial occlusion (AO). As a matter of course we prefer to use 225 to 250
mmHg to ensure halt of blood flow, inasmuch as this is possible. The DCS rBF
measurement is useful in this to verify the extent of flow reduction due to AO.
The rate of change from oxy-hemoglobin to deoxy-hemoglobin should then be
due to the tissue consumption of oxygen (see Figure 6). Thus V̇O2 can be
estimated by fitting the slope of the difference between [HbO2] and [Hb]. The
calibration of the baseline V̇O2 only requires a single minute of AO, which has
minimal impact on system hemodynamics (See Figure 6).
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Figure 6. Arterial Occlusion via HbO2 and Hb Difference Fitting
At the onset of occlusion, a transient initial increase occurred due to the slow (3-5 seconds) filling
of the cuff which induced sub arterial occlusion pressures and a very temporary venous occlusion.
The first minute of desaturation was fitted to determine the rate of change for calibration. The
occlusion was continued for another 2 minutes to observe flow/hemoglobin concentration changes
and the subsequent hyperemic/reperfusion response following the end of occlusion. These
parameters can verify the successfulness of the arterial occlusion and reinforce experimental
confidence in calibration values.

The change in hemoglobin concentration results in a unit of μM/kg/min and
may be converted to mlO2/100g tissue/min by knowing the molar ratio of 4 Mol
O2 to 1 Mol Hb, the molecular weight of oxygen (32 g/mol), the density of O2
(1.429g/L), and the density of muscle (1.04 kg/L)[18, 31]. As with the calibration
for flow there exists an approximate conversion factor of 1 μM ([HbO2]–[Hb])/
kg/sec which is approximately equal to 0.54 ml O2/100g/min[17].
2.5

Gating algorithm, Data Processing and Statistical Analysis
Data collection during exercise protocols is restricted to only periods of rest

between contractions by a gating algorithm. The gating algorithm, described
more fully in previous publications from this lab, uses analog output from the
dynamometer foot plate, with signal intensity dependence on footplate position, to
limit data collection to the time period between contractions[20]. When the foot
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plate is at rest position the dynamometer analog signal is below a certain
threshold and data collection is permitted. When the foot plate is moved through
the contraction range, the amplitude of the signal passes a threshold (set very
close to the resting position amplitude) and signals the DCS to halt data
collection. Without the DCS sending a TTL signal to the Imagent the FD-NIRS
remains on standby, following the return of dynamometer output to below
threshold levels the DCS/ISS data collection cycle resumes. By default a single
data point from each device is collected and then the cycle is halted to ensure that
the next contraction does not induce artifact, thus data collection only resumes
upon receipt of the return to rest trigger.
The processing and examination of data often requires the use of filters in
order to clearly display trends and behaviors. The only filter employed during the
extent of this research was a simple convolution (moving average) filter with a
window size of 10 or 20 data points, depending on the sampling rate. This filter
was chosen because it has a much less intrusive effect on data behavior,
particularly during the rapid onset and end exercise periods of these protocols
than does a Butterworth or equivalent filter. The convolution filter manages to
obtain the central tendency while still retaining the instability of the original data
set.
Student t-tests were used to analyze difference in time point means for all
tables and values in this thesis. The means used for these statistical analyses are
from overlaying time series and taking the mean of the entire time series thus
great importance was placed on the proper timing and synchronization of multiple
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systems of data collection. On some occasions, where a precise overlapping of
data is not possible, the region of interest is selected manually for each period and
subject, so that the period involved can be precisely controlled/matched between
subjects. An example of this is given for the strain gauge data sets which could
not, due to technical reasons (the two were measured on separate computers
without TTL links), be aligned exactly with DCS data frames and so venous
occlusion periods were selected manually for calculation based upon the time
point where volume began to increase and ended where the linear behavior ended.

34

CHAPTER 3: BASELINE HEMODYNAMIC ASSESSMENT AND
STABILIZATION

Blood flow baseline study protocols were begun by observing baseline
stability using DCS optical probe on calf muscles in the lower limb (Protocol #1,
see Chapter 3.1.1). After a review of literature and previous research in our lab
narrowed likely effects to be due to contact probes on muscle tissue, whereupon a
redesign of the optical probe pad (see Chapter 3.1.2) and attachment methodology
(see Chapter 3.1.3). Among these factors, local heating could possibly play a role
for the contact measurements since the probe pad covers the skin and is made up
of highly insulating materials. Furthermore, the contact probe is covered by
layers of surgical tape and compression bandage which also insulate the limb. If
a local heating were taking place it would possibly increase skin and muscle
blood flow[66-68]. Another possible flow modulator would be the application of
circumferential pressure due to the use of elastic bandage and wrapping tape
around the limb[56, 69-73]. Such wrapping was desired to secure the optical
probe due to the use of thick silicon rubber pads and bundled fibers and resulted
in a somewhat heavy optical probe. Taping and wrapping the probe were the
default methods of attaching DCS optical probes to tissue in all previous studies.
A second baseline measurement, from the same subjects and in the same calf
muscle indicated success in removing the predominant factor related to increased
blood flow (Protocol #2, see Chapter 3.1.4).
A confirmation protocol was then performed in the forearm flexor muscles
(Protocol #3, see Chapter 3.1.5), as the effect had been previously observed in
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both lower and upper limbs and a body of data existed against which we could
compare. This confirmation demonstrated a great increase in measurement
stability for the redesigned probe and showed that increases in rBF were, most
likely, due to predominantly local factors. Lastly the baseline study was
concluded by performing a repeat of the forearm flexor experiment using a subset
of those subjects and removing elastic bandaging from the protocol. Lack of
increase in the measured rBF for both arms suggested that elastic bandaging is
most likely to be solely responsible for previous baseline shifts whereas probe pad
contact is not a factor.
3.1 DCS Baseline Study Experimental Protocols
3.1.1

Protocol #1: Gastrocnemius Baseline Stability Evaluation

Before determining potential flow modulators and their effects it was
necessary to confirm the baseline shift through an extended in vivo resting
protocol in the muscle tissue of interest, the gastrocnemius. Examination of
resting muscle blood flow shift with DCS had never been done, making this a
novel measurement.
For the first experiment, 6 subjects (3 males and 3 females) were recruited and
their consent obtained via University of Kentucky Institutional Review Board
(IRB) approved forms. Subjects were instructed to lie supine and relax for at least
5 minutes prior to collection of data to allow flow to stabilize. The DCS optical
probe was secured to the limb as described in previous publications[15, 16, 28,
31, 44]. Briefly, the attachment protocol was to disinfect and clean the probe pad
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and probe site with alcohol prep. The probe was then placed in contact with the
subject’s medial gastrocnemius (location determined as the region of greatest
contraction during a plantar flexion) and lightly held by cotton surgical tape and
more firmly secured by use of an elastic bandage (ACETm) as illustrated in Figure
9. In this way external room light was reduced and probe position secured, even
during subject movements. It was deemed appropriate, as room lights were
dimmed to assist in preventing signal contamination, to engage subjects during
the experiment to prevent them from dosing or entering pre sleep states of
consciousness which can have substantial effects on pulse rate and blood
pressure[74, 75]. These conversations were of a generally neutral nature to keep
physio-emotional responses at a minimum whilst holding subject attention.
Retaining subject consciousness proved to be non trivial as we noted a distinct
tendency toward sleep due to the combination of low light, and highly static
supine bed rest for extended periods.
Baseline measurement duration was set at 40 minutes and the subjects
instructed to remain as still as possible, since DCS signals and the hemodynamics
of musculature in general are exquisitely sensitive to motion. Duration of
baseline measurement was extended to 40 minutes for two main reasons: first,
baseline shifts appeared to be a result of prolonged drift that was observed in
protocols lasting up to 40 minutes (with similar durations planned for future
studies) and therefore the presence/extent of any shift should be verified under
similar time courses. Second, no such extended evaluation of resting muscle
blood flow had been performed so determining the stability of passive muscle
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flow was relevant to understanding how meaningful a baseline measurement
could be in the first place.
A CW-DCS flow-oximeter system (see Figure 7), detailed in Chapter 1.6, was
used in this study. The CW-DCS flow-oximeter makes use of two wavelengths
(785 and 854 nm) of long coherence laser light for the source and uses 4 bundled
detector fibers at a single S-D separation of 2.5 cm as illustrated in Figure 7b.
This relatively large separation used was to ensure that the optical path was
predominantly inside muscle tissue and to minimize surface layer artifact. This
assumption is generally safe as all of our subjects had adipose tissue thicknesses
(ATT) of less than 8 mm over the gastrocnemius muscles[10, 72, 90].
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Figure 7. Fiber-Optic Probe and DCS Flow-Oximeter
The probe pad (a) consists of a simple foam block of dimensions 6×3×1 cm. The foam is black
and therefore an excellent isolator of probe signal from room light. The material is lightweight
and of intermediate stiffness, resisting curvature around the limb but conforming after application
of tape. Probe fibers are held firmly in perpendicular to the skin (not shown). Multiple holes exist
for adjustment of S-D separation. The DCS flow-oximeter (b) employs the 2 source, 4 channel
detector layout. Black coating is necessary for fiber optics to reduce external noise. The 4
measured autocorrelation curves for each source are averaged to produce a single relative flow
calculation.

The bundled detector fibers allowed for a higher data quality (SNR) compared
to a single fiber since the flow and oxygenation values can be measured in
quadrature for a single location simultaneously and averaged. This eliminated
some of the random noise and allowed for better quality data even in subjects with
low intensity signal (highly absorbing tissues). A sampling rate of 0.5 Hz was
used with one second of autocorrelation averaging for each source wavelength.
Flow values at both wavelengths were then averaged. After this averaging of
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flow between sources and calculation of relative hemoglobin concentration
changes from their intensities, a 10-point window convolution filter was applied
to further reduce high frequency noise and produce a smooth curve that shows the
central tendency of the raw data. Only raw data were used for statistical analysis
however, as filtering/sampling and other such data processing methods can have
effects on statistical power[76].
In addition to end point mean comparisons, extended baseline data stability
was evaluated with linear regression. It was determined empirically that most
baseline shifts tended to be pronounced after 20-40 minutes. Observed short
duration bidirectional fluctuations (occurring over 2-3 minutes and being 10-20%
rBF in magnitude) made mean comparisons non-optimal for assessing baseline
stability. This is because the peak of a short duration fluctuation at time point
could be present during the initial 2-minute mean period with the trough of a
fluctuation occurring during the end time period (or vice versa). This could render
the time point means statistically different while overall behavior suggested no
real variation over the long term. Rather than imposing harsh filters to remove
these physiological variations, a linear regression model to assess long term
baseline stability was used. Typical variation, i.e. standard deviation, of raw data
ranges between 15% and 30%, meaning at any time point a particular datum could
be, at worst, between 70% and 130% baseline. A linear model for stability
entailed applying a linear fit to the data and evaluating a slope of greater than or
equal to 0.7 (rBF/min) as a baseline shifted measurement. For a justification of
the model and slope threshold of 0.7, see the discussion in Chapter 3.3.1.
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3.1.2

Optical Probe Design Adjustments

Following the results of the first in-vivo DCS stability evaluation, we
determined that some aspect of the measurement was causing rBF to drift upward
(as shown in Chapter 3.1.1). This necessitated an investigation into possible
causes via a search of literature involving limb blood flow modulators. As
mentioned in Chapter 1, the two major suspected flow modulators were
temperature and pressure. Without the use of precise and somewhat invasive
probes, temperature and pressure data within the muscle were unavailable to us.
The lack of suitable measurement equipment for intramuscular/surface pressure
meant that we lacked a definitive way to measure either parameter, although the
use of the elastic bandage and tape virtually guaranteed that there were pressures
being applied to the limb, and that those pressures were probably sufficient to
affect local blood flow[56, 69-73]. Without hard data on either temperature or
pressure we decided that the probe/attachment protocol should be designed to
minimize the contributions from both parameters. Toward that end, the first line
of research was to design a probe pad which would be structurally robust as to
maintain source detector separations, provide a stable platform for optical fiber
insertion and constancy of optical geometry, and be easily and reliably attached to
the limb for repeatable measurements with the knowledge that such qualities must
be evident even during possibly strenuous exercise protocols. These necessary
qualities were of foremost importance as these are the conditions for getting
adequate signals and quality data with the minimization of probe pad area (for
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less insulation) and adhesive use, not to mention the removal of elastic bandage,
being crucial to eliminate possible flow perturbation.
It was determined that, based on several iterations of probe pad design, leaving
the area between the source and detector uncovered might reduce the temperature
effects as probe pad/tape insulation were minimized. By using a three sided
frame shape it was hoped that the attachment would be of sufficient integrity as to
be useful during exercise protocols but without the degree of taping/pressure
application as were present in the original probe (see Figure 8). Stability of probe
position and optical fiber geometry was achieved with the use of braided wire
struts. This design could maintain source detector separation but the strut, while
strong in the requisite source to detector axis, was flexible enough to bend
plastically so that no additional force pulling the fiber tips away from the skin was
present allowing the probe to match even the relatively severe curvatures of the
forearm.
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Figure 8. Redesigned Probe Pad and Attachment to Limb
(a) The fiber-optic probe held in place by the twist wires shown fiber tip length differences can be
adjusted to fit with spacers made of the same foam as the probe pad. (b) Probe pad shape allows
for a single S-D separation fiber arrangement. A separate probe pad would be necessary for each
distance as necessary to measure a particular depth. Wires secure the probe pad and fibers to
preserve the original orientation throughout the experiment. Tissue interface side illustrates the
diffuser, which covers the source fibers as discussed, and the detector fibers held flush to the probe
surface. (c) Shows the entire probe as it would be attached during protocols. The tegaderm film
has been vented over the open region of the pad to allow heat convection. Not shown is that the
fibers would be secured to remove their weight from the tissue surface and reduce amount/strength
of adhesive used to secure the probe.

An additional challenge arose in the form of isolated incidents of source laser
burning on the skin, despite the low power emission. Such burning was
hypothesized to be due to slight imperfections of the source fibers. In order to be
assured that no subjects would be burned, an optical diffuser was constructed
from Teflon. This polymer has a very low attenuation of NIR light and so does
not dramatically weaken the signal intensity of the source light but does broaden
the spot size of the source. The diffuser was created by shaving a thin block of
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Teflon until it was sufficiently thin. This thin (< 0.25 mm, as measured by digital
caliper) layer of Teflon prevents source fiber/tissue surface interactions without
significantly attenuating light nor decorrelating the light as the intensity and flow
signal are not apparently affected. More information about Teflon diffusers and
their effects on DCS may be found in the following citation [22]. The probe pad
now had all the qualities we were looking for in a DCS standalone system.
Attention now was turned to the problem of how to attach the probe securely
without applying excessive pressure.
3.1.3

Optical Probe Attachment Revision

After some investigation it was decided that a better alternative for surgical
tape adhesive was Tegaderm thin film dressing (3MTm) which allowed heat to
escape from the skin, had slightly better tack, and allowed the fiber/probe contact
to be visually observed during the experiment (refer to Figure 8c). The Tegaderm
adhesive proved effective and could be cut to allow a window over the source
detector area to vent air. Attachment of the optical probe to the limb by use of a
4х6 inch piece of Tegaderm thin film with a vent over the middle of the detection
path allows better convection of trapped heat away from the skin and no elastic
bandage was employed to minimize pressure application to the muscle tissue. The
weakness of this set up is that it is more prone to room light contamination and so
care must be taken to turn off room lights. Surgical tape may be used in lieu of
Tegaderm but should not be wrapped around the limb. Experimentally, a 7 inch
strip laid along the tibial axis and a 4 inch strip circumferentially proved to be
sufficient to hold the probe, as detected intensities were stable and no direct
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source to detector signal contamination could be discerned. Room lighting was
turned off for all baseline measurements and did not play constitute an optical
signal variable for this study but bears consideration for future experiments or
clinical applications where room lights may be required.
3.1.4

Protocol #2: In-Vivo DCS Gastrocnemius Baseline Stabilization

Probe/protocol redesign to remove DCS flow baseline shift was confirmed by
performing a 40-minute supine baseline test in 6 young healthy controls. The
redesigned optical probe (detailed in Chapter 3.1.2) was secured to the medial
gastrocnemius using surgical tape adhesive (as described in Chapter 3.1.3). The
same DCS flow-oximeter system was employed as described in Chapter 3.1.2
(Figure 8b) but with the probe design employed in Figure 9. Other than probe pad
and attachment no changes in procedure or data collection methodology were
made. Long term stability of data was evaluated by use of a linear regression and
slope examination. The slope threshold of 0.7 (refer to Chapter 3.1.1) serves as a
rubric for making judgments, in addition to end point mean comparisons, on
baseline stability.
3.1.5 Protocol #3: In-Vivo Forearm Baseline Stabilization and Examination
of Baseline Shift Origin

Following gastrocnemius measurements, we performed confirmation tests in
the forearm flexor muscles, in deference to the familiarity of our lab with
measuring this muscle group and fairly large subject populations of responses
against which to compare. We also attempted to identify the predominant factor
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causing baseline shifts using a subset of the forearm flexor subjects. This baseline
experimental protocol was designed using a concurrent forearm flexor
measurement protocol in which the right arm rBF was observed using the
redesigned probe/protocol and the left arm rBF using the original probe/protocol
(Figure 9). To ensure that the measurement was truly concurrent we used two
detector channels per probe with our 4-Channel 2-wavelength DCS flow
oximeter. This reduced the number of detector signals averaged, which led to
lower SNR, but guaranteed synchronicity in data collection and improved
sampling rates. In addition to the optical probes, a finger plethysmograph
(Portapres, FMS Inc., Netherlands) was used to observe systemic pulse rate and
blood pressure to determine global hemodynamic influence on local
measurements.
Ten young healthy control subjects were measured in supine for 40 minutes,
as detailed before. Probe position was kept consistent between subjects by
placing the probe over the region of maximum contraction of the forearm flexors
as determined by having subjects clench their fists. The entire protocol layout can
be seen in Figure 10.
After the completion of the 10 subject measurements, a subset (n = 4) of these
subjects repeated the measurement (on a different day but under identical
conditions) with the exception that the original protocol arm (left) did not employ
elastic bandage. This was done to examine whether removing the pressure
component of the original probe would reduce baseline shift, allowing us to judge
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whether or not probe pad insulation or pressure application was dominant in
inducing flow alterations (Figure 10).

Figure 9. Original Optical Probe Position and Attachment
Attachment was performed as depicted with tape to initially hold the probe (left), elastic bandage
to secure this position, and surgical tape to maintain elastic bandage pressure (right). The location
was based upon the maximum contraction response for clenched hands/flexed wrists. For
gastrocnemius measurements the probe was positioned based upon the greatest contraction during
plantar flexion in the medial gastrocnemius.

Figure 10. Concurrent Baseline Protocol Set-up
Subjects are positioned on a bed with head and forearms comfortably resting on padding/pillows.
Forearms are slightly elevated to reduce venous pooling associated with extended stationary
positions. Placing the hand at heart level also is required for accurate finger plethysmography
pressure and pulse rate data. Room lights are turned off and the subject is asked to remain at
resting supine for 5 minutes prior to start of data collection. 1) refers to the original probe and
attachment protocol on the left arm, 2) refers to the newly designed probe/protocol employed on
the right arm, and 3) indicates the finger plethysmography instrument.
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3.2

DCS Baseline Study Results

3.2.1

Protocol #1: In-vivo DCS Baseline Gastrocnemius Stability Evaluation

Relative blood flow significantly (p < 0.05) increased throughout the protocol
(refer to Chapter 3.1.1 for protocol details) from the first two minutes of baseline
to the final two minutes of the experiment for all but one subject (see Table 1).
The group mean of the final 2-minute value was 163.5 ± 5.9%, which
represented a tendency towards flow increase (see Table 1, Figure 11). The
significance of difference was determined via Student t-tests for the two groups
(initial 2 minutes of data vs. final 2 minutes). Subject 6 data was discarded as the
detected light intensity was only 10-15 KHz and the resulting calculated relative
flow, while in rough agreement with other subjects’ trends, was laden with noise
(standard deviations of greater than 90%). Only one subject (Subject 1) had a
trend uncharacteristic of the others. The change for this subject was also
significant but somewhat anomalous in that the trend was for decrease. The net
result is that the group mean response is higher than baseline after 40-minute
supine bed rest.

Table 1. Baseline Measurement Means and Fitting Slope
Subject

Group Mean

1
2
3
4
5
6

Initial mean rBF
Final mean rBF
Linear Fit Slope
(2 minutes)
(2 minutes)
100.0±23.6
87.9±52.6
-0.21
108.0±22.8
208.2±32.7*
3.41
105.1±9.4
217.8±15.4*
4.56
102.0±22.3
168.9±27.5*
2.39
99.6±6.0
122.8±14.1*
0.62
N/A
N/A
N/A
102.9±3.9
161.1±5.9*
1.39

Significance between data sets is denoted with an *.
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A linear fit of time series data showed a baseline shift that was in a distinctly
positive direction (Figure 11). While responses varied substantially between
subjects the increasing trend is consistent. For subjects with obvious elevations in
baseline, the statistical mean tests are sufficient to describe data, however, given
the somewhat large standard deviations associated with individual subjects for
particular time points, as discussed in Chapter 3.1.1, data stability in non-obvious
cases would be difficult to evaluate without resorting to unrealistically large
averaging times (5-10 minutes) and would still be greatly influenced by outliers
while linear models would be more insulated against such disturbances.

Figure 11. Group Mean (n = 5) Relative Flow with Linear Fit
Filtered mean data (green dots) demonstrate the central tendency of the data via a 10 point
convolution filter while standard error (red bars) demonstrates difference between subjects and
clearly shows an increase in flow during the baseline.

End value data for the old probe were significantly (p < 0.05) greater than
baseline, and were increasing at a substantially greater (slope = 1.46) rate than the
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0.7 model threshold for sustained elevation (Figure 11). For more explanation of
the linear fit slope threshold see the discussion in Chapter 3.3.1.
3.2.2

Protocol: #2: In-Vivo DCS Gastrocnemius Baseline Stabilization

The typical flow response for these same 6 subjects (see Chapter 3.2.1)
oscillated around the baseline value (Figure 12) throughout the protocol with the
revised probe (See Chapter 3.1.4) but some subjects exhibited a marked decrease
(15-20%) in flow (Figure 13).

Figure 12. Typical Subject Response with Redesigned Probe:
Stable Blood Flow
The most typical response to baseline protocol with the revised probe is a general stability around
100% with a minimal difference between end and beginning relative blood flow. The blood flow
naturally fluctuates around this baseline value highlighting the variable nature of microvascular
flow. A linear fit of the data shows an intercept close to 100% supporting the stability of the data
and the slope = 0.112 is much less than the empirical 0.7 threshold for a shift.

The decreases in flow (Figure 13) observed are likely attributed to the effect of
prolonged bed rest, for a justification of this decrease see Chapter 3.3.3. Systemic
indicators such as pulse and mean arterial pressure were considered to be
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important to facilitate a better understanding of these trends and were measured in
later studies.

Figure 13. Typical Subject Response with Redesigned Probe:
Decreased Blood Flow
The second typical response is that of a slight decrease (20%) from baseline. The linear fit of data
has a positive slope but has a substantially lower intercept which is indicative of the stability of the
latter part of the data following an initial 10 minutes period of decrease. This highlights the
weakness of using a linear model to describe nonlinear systems and would also indicate that the
some subjects can experience a slightly stressed state for longer than 10 minutes even at rest and
following at least 5 minutes of supine experimental set up.

Group mean response was an oscillatory and slightly decreasing time course
with end mean values comparable to the initial baseline value (Figure 14).
Despite the degree of variation of blood flow in time for each subject, the mean of
each subject showed remarkable stability which supports our hypothesis that the
removal of insulation and pressure application from probe design stabilizes the
system (Figure 14).
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Figure 14. Group Mean Comparison of Original (n = 5) and
Redesign (n = 6) Gastrocnemius Baselines
The redesigned probe (bottom) has a final mean value (final 3 minutes) of 93.3% of baseline
compared to the initial (3 minutes again) value of 102.5 and a linear fit slope of -0.356 which is
less than the 0.7 value attributed to describe a baseline shift. This is compared to the initial (3
min) mean of 102.9 and final (3 min) mean of 163.5 for the previous probe (top) and its obvious
shift of 1.46, which is double the empirical threshold of 0.7.

Statistical analysis of these data sets showed that the initial values of the
group means for either probe (first 2 minutes) was not significantly different
meaning that both studies had a stable initial relative blood flow and that the
difference between end values would then reflect the long term effects of the
probes/protocol on relative blood flow. The same analysis, applied to the final 2
minutes of each group mean time course, showed significant difference between
the two with the redesigned probe having a value significantly (p < 0.05) lower
than both the initial 2 minutes of the measurement and the final 2 minutes of the
original probe baseline. The redesigned probe data stability (as assessed by linear
fit), is much increased compared to the previous probe design with a reduced
slope and magnitude of difference in end points.
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These results support the hypothesis that the baseline shift was induced by our
measurement protocol and that the redesign (see Chapter 3.1.2 and 3.1.3) of said
protocol was successful in reducing the effect.
Table 2 summarizes the individual and group mean initial and final 2-minute
time period means as well as which ones are significant and the linear fit slope of
each.

Table 2. Probe Redesign Summary for Gastrocnemius Baseline
Subject

1
2
3
4
5
6
Group
Mean

Revised Probe
Initial mean rBF
(2 minutes)
102.3±6.5
103.5±7.5
106.1±12.8
104.2±22.6
97.8±14.3
100.9±7.1
102.5±2.5

Revised Probe
Final mean rBF
(2 minutes)
101.7±5.5
101.5±8.1
65.7±15.0*
102.8±16.4
85.6±13.3*
102.8±10.6
93.3±1.7*

Linear Fit Slope

0.11
-0.17
-0.55
0.13
-0.39
0.20
-0.36

The smaller changes in baseline over the 40 minute duration and the linear fit slope of values
(magnitude as well as direction) demonstrate a marked improvement of measurement stability in
vivo for the redesigned protocol. Standard deviations are less than those of the previous probe
which suggests an improvement in the S/N ratio for these data sets.

3.2.3 Protocol #3: In-Vivo DCS Forearm Baseline Stabilization and
Examination of Baseline Shift Origin

The use of relatively larger subject population (n = 10) and concurrent
measurements enabled us to determine a significant difference (p < 0.05) between
local hemodynamics in both limbs during the 40-minute baseline protocol in
forearms (see Chapter 3.1.5). All subjects had significant changes in blood flow
compared to the baseline but only 3 had that change in the increasing direction.
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The remainder exhibited a decrease in final 2-minute rBF that ranged from 10 to
40%.

Figure 15. Typical Subject Contra-Lateral Relative Flow
Most subjects showed a significant decrease in rBF with a linear fit far below the 0.7 threshold for
the right arm with redesigned probe (top panel). This is compared to the obviously increasing flow
(mean 200%) in left arm with original probe (bottom panel), and a linear fit triple that of the
threshold (mean slope: 2.26).

Figure 16. Atypical Subject Contra-Lateral Relative Flow
Of the three subjects this one had the most extreme increased blood flow with values approaching
those expected during exercise. The left arm blood flow (original probe) increases to 370% of
baseline while the redesigned probe has a still significant 163% increase. Such dramatic increases
may be due to the involvement of systemic parameters.
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The two distinct response trends are best shown in Figures 15 and 16, the
atypical response (Figure 16) is characterized by a very large increase in blood
flow over the duration of measurement, increasing to 370% of the initial value in
the previous protocol arm and 160% in the redesigned probe arm. The expected
response (Figure 15) showed an increase in the old probe arm from 100 to 200%
of baseline and a decrease in the new probe arm of 100 to 75% of baseline.
Trends of increase in previous probe arm rBF and a much reduced increase in
redesigned probe arm, with the same systemic cardiovascular environment,
indicate that the baseline shift had been dramatically reduced and was caused by
local factors. Linear fits for each subject are characteristic for baseline shifts in
all previous probe arms but not for new probe arms, except for those atypical
response subjects (Table 3).
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Table 3. Summary of Relative Flow Data Baseline Means for
Contra-Lateral Forearm Measurement
Subject

Previous Probe
Initial mean rBF
(2 minutes)
1
2
3
4
5
6
7
8
9
10

Group
Mean
Subject

Group
Mean

96.8±24.6
105.1±16.7
108.1±14.7
95.5±42.3
106.0±13.1
102.2±30.9
95.4±15.1
100.1±11.1
97.0±13.1
111.2±16.4
101.7±1.8
Revised Probe
Initial mean rBF
(2 minutes)

Previous Probe
Final mean rBF
(2 minutes)
142.1±27.8*
232.2±17.8*
145.5±23.4*
124.2±15.4*
149.5±34.2*
224.4±21.6*
134.3±13.1*
195.4±25.5*
174.3±20.7*
367.3±29.6*
193.6±5.6*
Revised Probe
Final mean rBF
(2 minutes)

Linear Fit Slope

1.18
3.09
1.06
0.72
1.10
3.12
1.04
2.28
2.16
6.37
2.26
Linear Fit Slope

1
2
3
4
5
6
7

98.6±15.7
102.9±25.9
102.9±8.0
100.2±24.2
101.2±11.6
110.4±18.3
98.4±12.9

94.2±22.6
89.2±34.9
92.6±14.1*
80.2±19.1*
89.3±12.5
184.0±21.2*
69.2±10.9*

-0.30
0.16
-0.03
-0.84
-0.36
1.11
-1.13

8

99.0±16.2

60.8±11.1*

-0.99

9

105.6±22.2

228.3±46.7*

3.37

10

106.9±22.8

163.8±31.6*

1.32

102.1±1.8

119.1±3.4*

0.28

Significant change in baseline flow (p < 0.05) is noted for all subjects and group means and this
difference applies both to final 2 minutes vs. initial 2 minutes and to difference between final
2minutes for each probe. Note the larger standard deviations for these data as only two detectors
were averaged, which supports the use of a multiple detector bundle fiber device for better data
quality.
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Figure 17. Group Mean (n = 10) Contra-Lateral rBF with Linear
Fitting and Standard Error
The original probe design shows a steadily increasing trend that is consistent with gastrocnemius
baseline measurements but generally higher (slope = 2.24 in arm compared to slope = 1.39 in leg)
with an overall increase of 199.1% (arm) compared to 163% in leg. The redesigned probe shows a
behavior consistent with leg measurements. Redesign (small linear fit) but has a still significant
increase due mostly to a short onset increase. This increase is almost certainly due to the large,
rapid increase observed in the 3 anomalous subjects, as depicted in Figure 17, which would have
skewed the mean upwards initially but was offset by general trends of decrease for later time
periods. Even so, the end result is a minor (117.9%) elevation over 40 minutes and a linear fit
which suggests stable baseline.

Group mean time series show greatly reduced baseline drift in redesigned arm
with a linear fit of 0.29 and final value of 119% of baseline while relative flow in
the previous probe site rises dramatically to a mean 193% of baseline and has a
mean linear fit of 2.24 (Figure 17). Statistically the two arms had a non
significant difference in initial 2 minutes of baseline flow (p > 0.05) and a
significant difference in final baseline flow both between probes and initial 2
minutes values for each probe.
Systemic data trends show that subject systemic parameters may have played
a role in anomalous flow responses as both MAP and pulse rate increased for the
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subjects experiencing greatest contra-lateral flow increase (Table 3 and 4, Figure
17 and 19).

Table 4. Forearm Study Summary of Systemic Parameter Means
Subject

Subject Initial 2
mins MAP
(mmHg)
1
2
3
4
5
6
7
8
9
10

Group
Mean

64.0±4.7
73.0±4.2
99.2±6.5
~62
69.5±3.3
69.3±9.1
59.0±2.9
76.0±2.9
84.9±9.0
65.3±3.4
73.3±0.7

Subject Final 2
mins MAP
(mmHg)
64.8±4.7*
88.0±5.2*
~103
63.0±3.6
81.5±2.0*
76.1±6.3*
73.3±4.1*
88.0±2.2*
107.9±6.3*
87.5±5.7*
82.1±0.6*

Subject Initial 2
mins Pulse Rate

Subject Final 2
mins Pulse Rate

60.5±10.0
77.2±6.2
82.9±5.1
82.8±3.9
60.4±4.1
71.2±9.8
64.6±5.2
59.0±2.8
71.6±6.7
65.3±7.4
69.7±0.8

54.9±2.0*
62.5±4.9*
84.0±3.9
72.2±6.1*
58.5±4.1
61.7±5.2*
60.5±3.1*
56.4±2.7
70.8±7.1
75.2±4.6*
65.7±0.5*

Significant difference from initial baseline (denoted *) to end baseline is found in most subjects
but MAP and pulse rate often differ in direction. Pulse rate decreases, as expected in resting
subjects, and MAP increases although it is not well understood why. Some literature indicates that
compression of the limbs can induce reflexive MAP increase[77]. ~ indicate finger
plethysmograph recording errors which produced gaps in data collection for these regions, the
mean was taken from available data within this time period.

Group MAP response shows an increase from 73.3 to 82.1 mmHg while pulse
rate decreases from 69.7 to 65.7 BPM. Group mean values for both MAP and
pulse rate have significant changes in final vs. initial two minute mean values
with MAP increasing and pulse rate decreasing. These changes are consistent
with a body of literature that indicates increased vagal tone during supine postures
can produce increased blood pressure and decreased pulse rate[78-80].
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Figure 18. Group Mean (n = 10) Time Series for Systemic
Parameters
Despite a high degree of variation within each time series the overall behavior of systemic group
means is somewhat stable with a slight but significant (p < 0.05) decrease in pulse rate and a
similar magnitude significant increase in MAP.

Results from 4 subjects, elastic-free, sub groups show similarly stable blood
flow response with an absence of linear fits that meet the standard of baseline
shift occurrence (Table 5, Figure 19). Initial two minutes of baseline rBF held at
102.1% and 101.2% for both arms (the former being original probe, the latter
being the redesigned probe) and both demonstrated a significant (p < 0.05)
decrease to 89.7% and 93.8% of baseline respectively. Mean linear fits of rBF are
likewise indicative of stability with slope values of -0.32 and -0.29 for previous
and redesigned probe (Table 5). Changes in systemic parameters indicate that
overall pulse rate is decreasing during the protocol while MAP increases. These
effects seem consistent with previous 10 subject forearm observations and
produce a non-increasing, more stable rBF (Tables 4 and 6, Figures 17-19).
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Table 5. Summary of 4-Subject Sub-Group Relative Flow without
Compression Bandage
Subject

Original Probe
Initial mean
rBF (2 minutes)

1
105.8±14.9
2
103.8±28.9
3
97.6±11.9
4
98.7±10.3
Group Mean
101.5±4.6
Subject
Redesigned
Probe Initial
mean rBF
(2minutes)
1
98.9±31.8
2
106.2±38.1
3
95.1±11.3
4
103.5±13.9
Group Mean
100.9±5.7

Original Probe
Final mean rBF
(2 minutes)

Linear Fit Slope

124.5±24.5*
0.53
68.8±14.8*
-0.98
78.6±14.9*
-0.57
87.0±7.6*
-0.31
89.7±5.4*
-0.32
Redesigned
Linear Fit Slope
Probe Final
mean rBF
(2minutes)
104.6±50.5
-0.30
107.2±23.6
0.14
73.4±10.2*
-0.10
89.9±15.8*
-0.65
93.8±7.5*
-0.29

No subject had initial 2 minutes flow significantly different (p > 0.05) than 100%. Most but not
all had significantly (p < 0.05) lower final 2 minute rBF and multiple mean comparison. All linear
fits had slope < 0.7 and this applied to magnitude as for all but one subject.

Table 6. Sub-Group Systemic Parameter Mean Summary
Subject

1
2
3
4
Group Mean

Subject Initial
2 mins MAP
(mmHg)
83.1±9.5
58.6±3.3
89.1±4.7
89.7±5.6
80.2±1.3

Subject Final
2 mins MAP
(mmHg)
78.7±5.6*
76.8±2.5*
113.5±5.3*
80.7±5.5*
87.4±1.4*

Subject Initial
2 mins Pulse
Rate
78.6±8.4
64.5±4.5
67.0±8.2
58.9±4.7
67.3±1.4

Subject Final
2 mins Pulse
Rate
62.1±10.0*
71.9±5.7*
71.1±8.7*
55.6±5.3*
65.2±2.3*

Responses vary highly in both magnitude and direction. This inconsistency indicates that there is
no dominant probe related effect on either pulse rate or MAP. All changes from baseline are
significant (p < 0.05) but this is not very informative given the sample size.
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These two forearm muscle hemodynamic measurements show distinctly
different trends of response (Figures 17 and 19) with the most obvious effect
being seen on local rBF endpoints (Table 3 and 5). The changes in
cardiovasculature during the measurement were consistent with those of the 10
subject trial with a slight increase of MAP being observed and this increase in
pressure may be attributed to the supine posture rather than compressive vascular
reflex, given the absence of the elastic bandage[77-80]. Pulse rate appears to be
largely slowed during baseline study (given the significant decrease for most
subjects and group means) which is supportive of the assumption that all subjects
were measured at rest.
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Figure 19. Sub-Group Mean (n = 4) Contra-Lateral rBF with
Linear Fitting and Baseline Systemic Parameters
With the removal of the elastic wrap both probes had significant (p < 0.05) decrease in final 2
minutes rBF compared to initial 2 minutes but neither baseline or end final rBF was significantly
(p > 0.05) different from each other. The linear fit of both time series showed a tendency to
decrease and the magnitude of the shift was much less than our threshold of 0.7. Pulse rate is for
the most part stable around its initial value without trend in any direction. MAP shows markedly
more change in response but overall the extent of this increase remains fairly small (though
statistically significant). Greatly indicative of predominant elastic bandage effect on local
microvascular blood flow. Systemic parameters appear to be more independent of compressive
effects.
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3.3

DCS Baseline Study Discussion

3.3.1

Protocol #1: In-vivo DCS Gastrocnemius Baseline Stability Evaluation

Initial in-vivo contact probe data clearly showed that some aspect of the
measurement was inducing a slow hemodynamic response in the limb (see Table
1). Relative changes in hemoglobin were of no consequence with few consistent
trends, as would be expected in a resting baseline measurement. Subjects
possessed a slight increase in total hemoglobin (not shown) but, again, this change
was subtle and consistent with the more interesting changes in relative blood
flow. The absence of global systematic measurements (blood pressure and pulse
rate) in this protocol meant that baseline status had to be assumed and 5 minutes
bed rest prior to the beginning of the protocol was deemed sufficient but
confirmation via a finger plethysmograph was desired to confirm systemic status.
Linear fits were performed to characterize the global data trends for a more
useful examination of rBF changes over time. An empirically set threshold of
slope ≥ 0.7 was chosen to linearly model a significant baseline shift. Such a
threshold, not based on physiological theory and predicated solely on examination
of data, is justified as during our initial 40-minute baseline study it was found that
end point rBF data standard deviations (calculated for each subject from Table 1,
Chapter 3.2.1) averaged 28.4%. Against a theoretical final mean of 100% (ideally
stable), the z score for our measured final mean (161.1%) was 2.15 meaning that
it was more than 2σ or possessed a less than 5% rate of occurring due to chance.
A 1σ threshold for increase over 40-minutes indicates that an observed mean
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increase could occur up to 128.4% approximately 1 in 3 times. A linear fit slope
≤ 0.7 would have the effect that an increase in rBF (128% over 40 minutes with
intercept = 100%) would fall within a single standard deviation of the expected
100% final stable baseline mean, but larger slopes would not. That is to say,
starting at 100% theoretically stable rBF, the increase due to variance (within a
single standard deviation) over a period of 40 minutes can be up to 128%, given a
0.7%/min slope. Stated as an equation, stability was determined thusly: 128% =
m %/min ∙ 40 minutes + 100%; m = 0.7 (%/min)
Thus a linear fit of less than this would show that the overall tendency for
change is small (less than a standard deviation) and well within reason given our
data variation, a larger fit shows a drift that is larger than variance would predict,
and increasingly unlikely to be due to chance. Such an evaluation also minimizes
the influence of short duration (2-3 minutes), low magnitude (10-20%),
fluctuations as well as of high frequency noise observed on end point mean
comparison Intercepts of the linear fit were not considered important, as long as
they remained close enough (within 15%) to the initial baseline value of 100%
that this value could be assumed to be the stable end baseline value. Sudden
initial or final changes could potentially deviate intercepts sufficiently as to make
the simple linear model of stability/shift inaccurate but it was determined to be
sound enough to make a viable determination of baseline data behavior and was
used for all baseline analysis.
Short duration rBF fluctuations are hypothesized to be related to many
possible factors. e.g., subtle motion artifacts, postural contractions of nearby
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muscle groups, changes in breathing pattern, pulse rate, arterio-venous tone, blood
pressure, etc. that are difficult to accurately observe/monitor. Concurrent
monitoring with EMG may be useful to distinguish the local muscle activity and
assess the degree to which small muscle motions may affect blood flow but was
unavailable to our lab for this study.
3.3.2

Protocol #2: In-Vivo DCS Gastrocnemius Baseline Stabilization

The measurement philosophy for this optical research is to avoid invasive
methods to make hemodynamic or intramuscular condition measurements. Such
noninvasive oriented research is optimal for developing methods directly
applicable to the clinical environment given that all invasive procedures carry an
increased risk of infection. This does mean that we must assume intramuscular
conditions (relying upon literature for these assumptions), if they cannot be
observed without the use of invasive procedures. This means that the
methodology employed to mitigate possible contact probe effects was to reduce
overall probe area, while retaining previously mentioned structural elements and
signal stability, and reduce the amount of circumferential pressure applied to the
limb, in an attempt to avoid intramuscular pressure increases and temperature
elevation without being able to measure either parameter.
Several iterations of probe design were attempted and tested before the final
design was adopted. Attachment protocol iterations found that acrylic liquid
adhesives and similar substances were non optimal since most adhesives strong
enough to maintain stable probe position proved difficult and uncomfortable to
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remove as well as having some risk of skin irritation. In the end, the reduction of
probe pad weight and securing of fibers allowed the use of the thin film adhesive
Tegaderm which effectively reduced circumferential pressure application and
insulation of the measurement region. While not optimized for multiple
separations or adaptation of Imagent probe, the probe/protocol redesign
successfully reduced the degree of probe influence on resting baseline blood flow
over long duration measurements (see results in 3.2.2). Responses varied between
relative stability and slight, but significant, decrease in end-point mean
comparisons. All measurements, as well as the linear regression model of those
measurements, showed a recovery of stable baseline measurements (see Table 2).
The effectiveness of the linear regression model designed for assessing baseline
stability was demonstrated to be effective at determining between overall stable
and drifting blood flow trends for this study. This protocol was successful in
reducing baseline shifts by use of the redesigned probe and new installation, but
did not contain a means for identifying the dominant flow modulator responsible
for this behavior. As such, another protocol was necessary to isolate the dominant
variable influencing microvascular tissue hemodynamics. The next study
(Protocol #3) used a relatively larger sample size to add statistical power,
measured the forearm flexor muscles to confirm the phenomenon and its
remediation in a separate and previously affected muscle group, and differentially
measured attachment protocols and probe pad differences between limbs in a
subset of the sample population.
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3.3.3 Protocol #3: In-Vivo DCS Forearm Baseline Stabilization and
Examination of Baseline Shift Origin

At rest, in the supine position, there is a tendency for blood pressure (systolic
and therefore MAP) to rise and pulse rate to decrease[78-80]. Resting muscle is
absent working muscle related metabolic/mechanical vasodilatory signaling.
Given the lack of parasympathetic innervations of the muscular microvasculature,
the aforementioned MAP increases and myogenic response of feed arteries
produce an overall higher vascular resistance[81]. The decreased perfusion
pressure of the lower limbs in supine, coupled with increase in vascular resistance
and lack of vasodilatory stimulation, is seemingly able to produce a decrease in
muscular perfusion, thus the decreased muscle blood flow (rBF) trend during
these extended baseline measurements. This result is independent of the optical
probe set up and is a consequence of systemic/local hemodynamic response to
supine posture. Since no literature has been found which reports continuous,
extended, resting baseline microvascular flow, this data, while in agreement with
basic physiological principles, may be somewhat novel.
Removal of the elastic bandage removed subsequent baseline shift from the 4
subject subgroup regardless of which probe pad was used (see Table 5). This
lends support to the hypothesis that application of circumferential pressure on the
tissue to hold the probe pad in place is the predominant hemodynamic modulator
inducing a significant elevation in subject local relative blood flow. The increase
of MAP and blood flow in most subjects using the previous probe/protocol can be
majorly attributed to the compression bandage having a local and systemic effects
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which is linked to mechanically induced arterial vasodilation and autonomic
response[70, 71, 77-79, 82]. The decreases in rBF observed (both in
gastrocnemius and forearm flexors) during baseline measurements with revised
probe and protocol are likely a result of the prolonged supine posture[78-80].
Group mean data for the forearm studies (Protocol #3) agree with the findings
from previous gastrocnemius study (Protocols # 1 and 2) confirming that the
original probe design induces a baseline shift while the redesigned probe/protocol
does not.
Linear regression models successfully differentiate between short duration
increases and true tendencies to increase over the duration of the measurement.
The redesigned probe/protocol while significantly different from baseline (p <
0.05) at 102.1% to 119.1% only had a mean linear slope of 0.28, due to a sudden
initial increase in rBF that is subsequently stable. This mean behavior is
attributable to the effects of 3 atypically increasing subject responses offsetting
with the more normal decreasing response in the long term, resulting in an initial
increase followed by stability. These atypical responses are discussed further
below.
There were found to be 3 subjects whose rBF increased in both arms
regardless of probe/protocol and each of these was associated with the largest
increases in rBF for the previous probe design (see Table 3). While unexpected,
the data was accepted as reliable and a result of local/systemic hemodynamic
factors rather than some outside source of noise. This stance is adopted as the
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intensity and signal contact data were of good quality and no systematic or
protocol deviations were noted in any of these subjects.
Atypical subject responses are included in the group mean which helps to
explain the observed behavior therein. Most subjects had a final 2 minutes MAP
value either non-significantly or 5-10 mmHg higher than initial 2 minute means.
Subjects 9 and 10 exhibited drastic flow increases in both limbs and MAP
increases of 23.0 mmHg and 22.2 mmHg respectively which would amount to a
large increase in perfusion pressure at the microvascular level and at least
suggests a non-stable baseline global hemodynamic environment. Reasons for the
atypical increases could be attributable to some systemic upregulation (see the
MAP increases for those subjects) or local activity but are not certainly known.
Future studies must be cautious in applying protocols with attention to detail to
prevent unknown variables from inducing potentially large changes in the
sensitive microvascular hemodynamics.
In summary, despite the anomalous data, the general trend for the 10 subject
group is in agreement with the previous gastrocnemius study (Chapter 3.2.1 and
Chapter 3.2.2) in that previous probe/protocol application induced significant
increases in resting baseline rBF while the redesigned probe/protocol greatly
stabilized the measurement over the duration of the protocol. By concurrently
measuring forearms with different optical probes, this study gives us reason to
believe that local hemodynamic parameters are predominantly at the heart of the
baseline shift and are likely related to vascular tone changes in the underlying
muscle at the probe site[66-70]. This stance is further supported by highly
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divergent local responses given the same global increases in MAP and decreases
in pulse rate, expected of prolonged supine bed rest (see Table 4).
3.4

DCS Baseline Study Conclusions

Following the completion of analysis on both leg and forearm studies, it can
be ascertained that the original contact probe and attachment protocol were
inducing a significant flow perturbation, likely by way of inducing local
vasodilation via elastic bandaging[16, 31, 69, 72, 73, 77]. Without being able to
measure the intramuscular conditions regarding heat and pressure we attempted to
design around evaluation of both parameters and obtained a final design that was
efficient in terms of probe weight, easy to use, possessed of rigidity, durability,
and fiber optic support. This redesign subsequently appeared to stabilize in vivo
measurements. Study in both the gastrocnemius and forearm found the newly
designed probe/protocol reduced the contact measurement hemodynamic effects
which was significant with regards to local blood flow shift. An additional
advantage to the major findings is that the probe pad was not the dominant factor
in measurement induced hemodynamic shifts and we can therefore apply the
hybrid DCS/Imagent probe (Illustrated in Figure 20) to measure absolute
quantities for both flow and oxygen consumption rate, following the appropriate
calibration protocols[31, 32].
Having satisfied our 3 major aims for this blood flow baseline shift study, i.e.,
verifying the presence of a gradual increase in rBF in healthy controls, stabilizing
the measurement through probe redesign and protocol adjustments, and
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ascertaining the origin of the baseline shift, we were now able to make continuous
measurements in vivo with confidence that the measurement procedure itself was
as minimally intrusive to the observation as possible.
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CHAPTER 4: TRANSLATION OF ABSOLUTE
HEMODYNAMIC/METABOLIC MEASUREMENT METHODS TO THE
GASTROCNEMIUS DURING DYNAMIC EXERCISE

Our lab had previously investigated hemodynamics of the lower limbs using
DCS/NIRS oximetry and validated this data against other technologies[16, 28].
However, these methods involved previously described optical probe attachment
which was demonstrated to induce instabilities in rBF which we believe to have
been addressed using current methods. In addition to this, our recent use of
calibration techniques and dynamometer controlled exercise protocols[31, 53] had
not been tailored to the lower limb, nor had we developed a protocol for exercise
that would be easily comparable to literature. This research then focused on
addressing these by developing an exercise and calibration protocol for use in the
lower limb that would be comparable in duration/intensity to those of literature
and, optimally, can be done by both healthy controls and PAD patients [13, 18,
19, 31, 54, 83, 84]. The success (or failure) to produce consistent and comparable
responses would determine if these techniques were sound and would offer a
platform to extend measurement to patient populations.

4.1

Gastrocnemius Translation Experimental Protocols

The primary motivation for using such an exercise protocol was in developing
a protocol that could examine working muscle tissue hemodynamics and also be
used to compare between healthy controls and PAD patients. By applying our
recently developed calibration and measurement methods to the lower limb, this
study would provide us a set of hemodynamic responses in young healthy
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controls, using a protocol adapted to our equipment, as was the case in previous
forearm studies[20]. The successful transference of our calibration and
measurement techniques in the lower limb would then be our basis for
comparison in future studies, perhaps in healthy control populations age-matched
to standard PAD populations.
Secondary to the above motivation was the desire to cross-validate our resting
baseline BF measurements using strain gauge plethysmography (SGVP) during
our previously described microvascular flow calibration measurements. Such
investigation marks a unique aspect of this study, as we had not previously
concurrently validated our absolute measurements, but only compared the results
of NIRS blood flow calibrations with literature. By concurrently measuring
resting blood flow with both methods during the same venous occlusions we
could remove procedural, temporal, and subject population variables from
consideration and directly validate our optical methods. Methods employed here
would make one of the few studies to comprehensively document muscle
microvascular blood flow, limb blood flow, muscle blood oxygen saturation, as
well as the derived metabolic parameter of oxygen consumption rate,
continuously during dynamic exercise.
4.1.1

Subjects and Measurement Setup

10 subjects (2 females, 8males) were recruited and were all generally young
with a mean age of 28 ± 2.8 yrs and without any known medical conditions.
None were taking medication for any cardiovascular disorder. Subjects were all
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active, engaging in activity multiple times per week but none were involved in
regularly strenuous exercise regimens and none had participated in any exercise
the day of the measurement. Subjects were recruited on a voluntary basis from a
pool of healthy individuals and agreed to be measured via signed University of
Kentucky Internal Review Board (IRB) approved consent forms.
The subjects were positioned in supine with head supported by a pillow and
right arm supported at heart level, for the measurement of systemic pressure/pulse
via finger cuff plethysmography. A finger plethysmograph (the same used in
Chapter 3.3) was secured to the middle digit and used to monitor mean arterial
pressure and pulse rate during the exercise protocol. Supine posture was used to
more directly compare our data to other studies that, predominantly, used supine
postures[13, 31, 54, 65]. Velcro straps secured the foot to the plate and the
elevation of the dynamometer head was then raised to slightly above heart level.
An inflatable thigh cuff (Zimmer ATS 1000, Indiana) was secured around the
thigh above the knee firmly but without squeezing the leg. This cuff was then
primed with a brief inflation. This served to set the tourniquet, fixing its position
and decreasing the time to inflation during later occlusions.
Tissue hemodynamics were collected by using the FD-NIRS/DCS hybrid
optical device. As described in Chapter 2.1 a commercial Imagent NIRS oximeter
was used to acquire tissue oxygenation data and DCS was used to obtain rBF,
from which the derived parameter (relative changes in oxygen consumption rate)
could be calculated. The hybrid DCS/Imagent flow oximeter probe (Figure 20)
was attached to the medial gastrocnemius of the test leg, after sterilizing both the
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probe site and probe pad with alcohol preps. Adipose tissue thickness (ATT) was
measured at the probe site before attaching the probe using a manual caliper
(Lange 85300, Texas) three times consecutively and the result averaged to
produce a determination of the optical barrier.

Figure 20. Hybrid Optical Probe
The hybrid optical probe consisting of a modified Imagent ISS optical probe. The silicone block
had holes punched to accommodate the bundled 2-wavelength (785 and 853 nm) DCS source
fibers and the 5 bundled single mode DCS detector fibers. This silicone rubber is 1cm thick and
black which makes it an excellent shield to external noise, as well as having sufficient pliability to
conform to the curves of human limbs and thus make good contact.

The optical probe pad was secured to the medial gastrocnemius with clear thin
film adhesive dressing (Tegaderm, 3M, St. Paul, Minnesota) or two 6 inch strips
of surgical tape one placed along axis of the muscle and the other in the
circumferential direction (with care not to compress the muscle only to apply
enough force to secure the optical probe). The strain gauge was placed just above
the probe pad, underneath the tape layer and in the “shadow” of the pad such that
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tape did not grab the strain gauge or pull on it which would induce artifact; this
was easily verifiable by observing the strain gauge signal during final application
of tape. Signal sensitivity of the strain gauge plethysmograph (Hokanson E-4
Strain Gauge Plethysmograph, Bellevue WA) was set to 1%. The device was
then electronically calibrated and zeroed to the subject’s resting limb
circumference. Strain gauge signals were recorded via a visual basic program and
written to a text file with the computer time stamped to assist in alignment of data
with DCS data. Sampling of analog signals from an AD board was set at 1 KHz
and 200 data points were then averaged to produce a final sampling rate of 5 Hz.
This data was read into MATLAB for processing along with the DCS/Imagent
data. Once the probe was secured, the optical fibers were taped to the bed to
remove their weight from the probe and reduce negative pressure on the muscle
belly. The signal was then tested and the probe pad readjusted, if necessary, in
order to maximize signal integrity. Upon completion of the instrumentation set up
(~5 minutes) a calibration protocol was performed. The entire experimental
layout is demonstrated in Figure 21.

76

Figure 21. Equipment and Exercise Protocol Set-up
(1) DCS/ISS Hybrid Equipment; separate control computers connected via TTL link and receive
analog position input from dynamometer to gate data collection during exercise. Total sampling
rate (consisting of alternating between DCS acquisition and Imagent acquisition) is 1 Hz. (2)
Optical probe sited over medial gastrocnemius at location of the muscle belly. (3) Occlusion cuff
secured above the thigh for inducing venous occlusion and arterial occlusion for calibrations. (4)
Strain gauge and control computer run independently and concurrently during both calibration and
exercise protocols. Sampling rate set at 100 Hz with an average of 50 data points per recorded
data point for overall data collection of 0.5 Hz. (5) Dynamometer is used to control exercise
workload and frequency via setting 30% MVIC resistance and passive return to rest. A visual
metronome is used to regulate subject timing.

4.1.2

Calibration Protocols for Absolute Hemodynamic Measurements

The calibration protocol consisted initially of a 3minute resting baseline
measurement. Following that, a series of calibrating occlusions was performed.
These consisted of three, 10-second, 50 mmHg, venous occlusions (VOs) with 1minute of recovery between each occlusion. The change in THC during each VO
was approximated by a linear fit and then averaged to produce the mean change in
tissue compartment blood volume. This volume change, in units of μMol/kg/min,
was converted to the perfusion units commonly used to describe tissue blood flow
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as previously described (Chapter 2.3). These same VOs were used to compute the
limb blood flow based on the increase in strain gauge resistance caused by
volume increases during the occlusion. Concurrent strain gauge blood flow
values were used to cross validate initial blood flow calibration. Next a single, 3minute, 250-mmHg, arterial occlusion (AO) was performed wherein the fitted
slope of the difference between [HbO2] and [Hb] during the first minute provided
the baseline muscle tissue oxygen consumption rate measurement, as described in
Chapter 2.4. Following the AO, 5 minutes of recorded recovery allowed
affirmation that the subjects’ hemodynamics had returned to baseline values. The
calibration protocols required ~15-minutes in total to complete and its
organization summarized by Figure 22.
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Figure 22. Absolute Hemodynamic Calibration and 30%MVIC
Dynamic Plantar Flexion Protocol Layout
The above diagram summarizes duration and timing for each procedure. The black dotted box
signifies the period in which the gating algorithm is active, and thus the sampling rate reduces to
0.5 Hz. Otherwise overall data sampling rates are 1 Hz as has been discussed.

The FD-NIRS Imagent collected data using a sampling rate of ~7 Hz to
capture 5 data points ([Hb], [HbO2], THC, and StO2) per second to increase the
temporal resolution of the hemoglobin concentration measurements and promote
optical sensitivity to the calibration occlusions. Afterward DCS flow data
(sampled for 300 ms) collected a single rBF data point. The overall sampling rate
for both devices was 1 Hz. DCS and Imagent data collection was controlled by
TTL signals to protect the integrity of each optical signal.
Following the calibration protocols, data collection was halted and the
calibration data file saved, after which the subject’s maximal voluntary isometric
contraction (MVIC) load was determined. This procedure was used to normalize
79

exercise load to a percentage of each subject’s maximal strength thus attempted to
remove subject strength/fitness as a variable. The MVIC test consists of three to
five, 5-second, isometric (static plate) contractions with three consecutive
plateaued work outputs. The average of these values is used to determine the
maximum force generation for each subject’s plantar flexor muscles. The plantar
flexion resistance was set as 30% of the MVIC and the subject was allowed to rest
while the instrument settings and data file for the exercise protocol were prepared.
Following the MVIC determination subjects were given a brief (5-6 cycles)
exercise training to familiarize them with the exercise protocol to be performed.
Subjects were given at least 5 minutes of recovery between MVIC test and
exercise baseline measurement while investigators saved calibration data files and
adjusted optical instrument data collection to exercise regime.
4.1.3 Gastrocnemius Hemodynamic Assessment During 30% MVIC
Dynamic Plantar Flexion Exercise

After taking 3 minutes of baseline data to reconfirm measurement stability,
subjects then performed 3 minutes of 0.5 Hz, 30% MVIC, full range of motion
(15-30°) plantar flexion exercise. Exercise rhythm was preserved by use of a
visual metronome and examiner prompting, in order to keep the duty cycles as
consistent as possible. Each duty cycle consisted of a 0.5-second contraction, a
0.5-second relaxation to rest position, and a 1-second passive rest following the
contraction/relaxation phases. Data collection was limited to this one second rest
phase by the use of a gating algorithm (see Chapter 2.5). Immediately upon
reaching the end of contractions, a single 50 mmHg VO was performed to assess
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post exercise limb flow via SGVP. Fifteen minutes of post exercise recovery
hemodynamics were measured to assess long term muscle metabolic/flow
responses to rigorous exercise. Refer to Figure 22 to review the overall protocol
layout.
During exercise protocols the FD-NIRS data collection regime was adjusted
to 7 waveform averages per data point (300 ms total sampling time) and the
measurement ratio set 1 to 1 with the DCS flow measurements. This decreased
the temporal resolution of hemoglobin concentration measurements but increased
sampling time for a single data point, thus increasing the signal-to-noise ratio of
these measurements for more accurate determination of hemoglobin concentration
and V̇O2 changes. DCS was set to a correlation/sampling time of 600 ms for a
single data point and thus the total sampling rate for the protocol was 1 Hz, except
where this 1-second of data was gated to collect between 1-second duty cycles,
reducing overall sampling rate to 0.5 Hz during exercise.
File markers were used to indicate time points for the beginning and ending of
exercise for offline data analysis. During the experiment, the DCS and Imagent
operating programs displayed, on their respective screens, the online relative flow
index, absolute hemoglobin concentrations, and tissue oxygen saturation. The
calibrated blood flow and derived oxygen consumption rate were calculated via
offline analysis using MATLAB processing code. Data from the Imagent, DCS,
and finger plethysmography were co-registered using file marker time stamps so
that all data from the three devices could be aligned precisely.
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4.2

Gastrocnemius Translation and Hemodynamic Profile Results

4.2.1

Subject Demographics and Calibrated Baseline Values

Exercise strength normalization with MVIC produced comparable working
loads that were a mean of 28.1 Nm. Pre-measurement ATT was normal for all
subjects and did not pose substantial optical barrier. All subjects were able to
complete the protocol and initial values (see Table 7) indicate healthy resting
values for controls.

Table 7. Subject Demographics and Measured Resting Baseline
Values
Subject Demographics and
Key Protocol Values
Age (yrs)

Mean±Std

ATT (mm)

6.4±1.5

MVIC (Nm)

93.7±26.5

Mean Power (W)

13.5±3.4

Baseline StO2 (%)

72.6±3.0

Baseline Optical BF
(ml/100g/min)

0.88±0.4; Optical

Baseline SG BF
(ml/100g/min)

1.13±0.6; Strain Gage

28±3

Individual data were shown for a single subject (Subject 4) in Figures 23-25
during calibration. Values were obtained for the resting conditions for flow and
oxygen consumption rate from our calibration protocols of venous occlusions and
arterial occlusion. Characteristic trends included the rBF dramatically decreasing
during AO, the slight decreasing in rBF during VO, and the hyperemic overshoot
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following AO of about 225%. Clear desaturation and separation of Hb/HbO2
indicated successful V̇O2 calibration. THC trends closely mirrored those of the
strain gauge as demonstrated in figures 25 and 26; these calculated blood flows
were demonstrated to be simultaneous by time axis examination (Figures 23 and
24). All values returned to baseline levels following five minute recovery
periods.
Group mean calibration was consistent with individual subject data for all
parameters. Cross validation of initial absolute blood flow was successful during
baselines. A correlation R2 = 0.51 for mean individual absolute NIRS blood flow
and SGVP blood flow was observed (Figure 26). Mean initial blood flow for
muscle tissue was comparable but significantly lower than limb blood flow
measured by the strain gauge (Table 8). However, limb blood flow was observed
to only be an average of 1.3X greater than local blood flow in contrast to the 2-3X
previously reported in literature[12, 13, 65]. Repeatability for each occlusion was
good with mean strain gauge measurements having a standard error of 0.63 ml
blood/100ml tissue/min and with NIRS occlusions having a standard error of 0.35
ml/100ml tissue/min (Table 8).

Baseline values for NIRS blood flow

measurements agreed well with literature values, finding a wide range from 0.35
to 1.36ml/100ml tissue/min (Table 8) [14, 17, 31, 61, 63, 65]. The strain gauge
values were lower than most literature, ranging from 0.4 to 2.4ml/100ml
tissue/min (Table 8)[27, 64, 85, 86]. V̇O2 measurements are likely underestimates
with a mean 0.049 mlO2/100ml/min. However the range of 0.023 to 0.127
mlO2/100ml/min measurements agree with literature reports finding values of
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around 0.02 to 0.15 mlO2/100ml/min, with a typical mean of 0.1
mlO2/100ml/min[12, 14, 31, 61, 63]. This might be related to the known arterial
leakage that occurs even when using 50+mmHg of pressure over systolic
pressure. The small influx of oxyhemoglobin depresses the decrease occurring
due to occlusion and makes the [HbO2-Hb] difference smaller, thus the
underestimate.

Table 8. Subject Initial Absolute Calibration Values
VO Calibrated
Optical BF
(ml/100ml/min)
Subject 1
Subject 2
Subject 3
Subject 4
Subject 5
Subject 6
Subject 7
Subject 8
Subject 9
Subject 10
Mean±std

VO Calibrated
SG BF
(ml/100ml/min)

1.04±0.06
1.36±0.11
1.33±0.06
0.61±0.13
0.62±0.16
0.35±0.16
1.03±0.35
0.46±0.01
0.95±0.35
1.07±0.32
0.88±0.35

1.18±0.05
2.40±0.07
1.94±0.15
1.29±0.08
1.03±0.06
0.57±0.09
0.46±0.16
0.41±0.03
1.04±0.10
1.01±0.06
1.13±0.63

AO Calibrated

V̇O2

(mlO2/100g/min)
0.009
0.127
0.023
0.057
0.030
0.036
0.058
0.027
0.059
0.068
0.049±0.033

Each flow value is shown as the mean ± std of three VO flows. V̇O2 is shown as a single AO
measurement only. Group means are presented as mean ± standard error.
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Figure 23. Sample Subject (Subject 4) Hemodynamics and
Strain Gauge Data During Calibration Protocol
Descending order: Deoxy, Oxy, and total hemoglobin concentrations, StO2, rBF (with raw data in
blue, filtered in green), and strain gauge data at bottom. Hemoglobin trends, oxygen saturation,
and rBF trends indicate successful occlusion; rBF decreases during VO supporting the assertion
that these pressures do in fact decrease flow to the limb[27].
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Figure 24. Zoom-in Sample Subject (Subject 4) Optical THC and
Strain Gauge Data During VO
Volume changes measured by both strain gauge(bottom) and NIRS(top) concurrently, indicate that
the effects of the VO upon vasculature are immediate and detectable by both systems. Correlation
of individual VO volume changes between the two methods resulted in R2 values of 0.93, 0.88 and
0.98 respectively. These correlations decreased once the conversion factors to acquire perfusion
units were applied suggesting a disconnect between the set of assumptions used to calculate local
tissue perfusion and limb volume changes assumed to equal flow. Black lines are the plotted
linear fits of each occlusion.

Figure 25. Zoom-in Sample Subject (Subject 4) V̇O2 Calculation
During AO
Rapid decrease in oxygenated hemoglobin and simultaneous increase in deoxygenated
hemoglobin causes the difference to approach zero during the occlusion period. This rate is
estimated via MATLAB polyfit and produces a slope (shown in black dotted lines) which may be
converted from units of μMolO2/min to units of mlO2/100g tissue/min. Note the initial increase is
likely due to the cuff taking time to reach fully occlusive pressures. Only the first minute of
occlusion is necessary to obtain an estimate of oxygen consumption rate, the remainder is used to
assess the overall quality of the occlusion.
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Figure 26. Correlation Curve for Baseline Absolute Blood Flow
Between NIRS and Strain Gauge Plethysmography
A correlation of R2 = 0.51 was obtained which indicates a sound correlation between the two
parameters despite high degrees of intersubject variation and differences between limb and muscle
flow (to which the remainder of variance is attributed). Strain gauge measurements are generally
higher than optical methods as has been noted by most NIRS flowmetry groups. On average the
difference was local blood flow measurements by the optical device was 78% lower than strain
gauge measurements.

4.2.2

Gastrocnemius Hemodynamic Profiles During Exercise

Individual data for the same subject (Subject 4) are presented in Figure 27 to
illustrate typical individual hemodynamic profiles during the exercise protocol.
Exercise baseline data for hemodynamic parameters were stable. This subject, as
is typical, shows clear initial changes due to exercise including decrease in THC
caused by muscular compression of the compartment. StO2 decreases sharply
while rBF increases rapidly, contributing to the substantial rV̇O2 increase. At
onset of exercise these values changed rapidly and a plateau was achieved within
about two minutes of exercise with significant increases of ~350% rBF and
~600% rV̇O2. Absolute optical BF was 2.4 ml/100mltissue/min while SGVP
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measurements resulted in 3.1 ml/100mltissue/min, reasons why SGVP blood flow
are larger than NIRS are discussed in chapter 4.3.2 and the appendix. Neither
parameter recovered completely 15 minutes post exercise, remaining significantly
elevated by approximately 2 fold compared to baseline. Tissue desaturated
significantly to 55% from an initial 70%, recovering to sustained super baseline
levels following exercise. Subject pulse rate and MAP increased to 90 BPM and
105 mmHg respectively with end recovery pulse rate recovering completely (not
significantly different from baseline) while MAP remained elevated, similarly to
rBF, at 95 mmHg at the end of data collection. Strain gauge signal was stable
except during exercise where noise was substantial due to muscle contractions
changing limb volume (Figure 27). The post-exercise VO is observable in
hemoglobin (with increases in THC) and strain gauge (increased volume) data
indicating a successful occlusion.
Group mean results were similar in trend to those of individual data, as seen
in Figure 28 and Table 9. All the following changes were significant (p < 0.05)
compared to baseline. Tissue desaturated by a mean of 13.4% compared to
baseline (71.1 to 57.7%) while both local hemodynamics and systemic
cardiovasculature rose rapidly. All of these were indicative of substantial effort
on the part of the subject population. Recovery was rapid but incomplete with all
parameters except pulse rate being significantly greater than baseline, a response
that has been observed elsewhere[87]. Mean BF increased from 0.91 to 1.87
ml/100mltissue/min (220%) while V̇O2 increased from 0.05 to 0.17
mlO2/100gtissue/min (326%). Strain gauge mean BF increased from 1.13 to 5.13
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ml/100mltissue/min (454%) with a large standard deviation of 3.15 (standard
error 1.1) ml/100mltissue/min due to subjects having a range from 2.5 to 12.8
ml/100mltissue/min. This data was then regarded as unstable, as discussed in
chapter 4.2.2 and the appendix. MAP and pulse rate increased from 77.9 mmHg
and 63.5 BPM to 91.9 mmHg and 82.7 BPM respectively. The majority of
recovery occurred within the first minute following end of exercise as can be seen
by observing the end exercise, 1-minute recovery, and end-recovery values, as
well as time series data (Figures 27 and 28; Table 9).
Consistency between subject responses to the protocol resulted in minimal
temporal blurring of the rapid onset and end exercise trends, along with fairly
small standard errors. The VO used to assess end exercise flow via strain gauge
may be observed in the individual subject data (Figure 27, hemoglobin) but was
not evident during the group mean response (Figure 28, hemoglobin). The
interference with hemodynamics during this period was less than the variation
that occurred between subjects responding to the same stimulus.
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Figure 27. Sample Subject (Subject 4) Exercise Protocol
Hemodynamic Response and Strain Gauge Data
Descending order: Hb, HbO2, THC, StO2 and coaxial rBF and rV̇O2, followed by systemic pulse
rate and MAP, and lastly strain gauge limb volume changes. Exercise periods are marked by the
first two vertical lines, the second of which also indicates the time of post exercise VO initiation.
The third vertical line indicates the end of VO and beginning of recovery.
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Figure 28. Group Mean (n=10) Hemodynamic Profile for
Gastrocnemius Muscle During Exercise
Mean responses (with standard error bars) show clear effects of exercise, both locally and
systemically. Strain gauge BF relative increases are much greater than DCS flow and have
standard error of 85% which could not be shown in this figure.
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Table 9. Summary Values for Blood Flow, Oxygen Consumption
Rate, and Systemic Parameters
Hemodynamic
Parameter

Initial
Calibration

Baseline
Exercise

End Exercise

1Minute
Recovery

End Recovery

rBF (%)

102.1±7.6

100.9±2.9

220.4±9.5 *

144.0±4.4*#

158.7±4.3 *# ^

BF
(ml/100ml/min)

0.88±0.4

0.91±0.03

1.87±09 *

1.39±0.04*#

1.53±0.05*#^

SGBF
(ml/100ml/min)

1.13±0.6

n/a

5.13±1.0*

n/a

n/a

rV̇O2 (%)

99.6±1.7

103.7±1.5

326.9±15.5*

164.6±6.8*#

145.1±3.8 *#^

V̇O2
(mlO2/100g/min)

0.05±0.03

0.05±0.01

0.17±0.01 *

0.07±0.02 *#

0.08±0.01*#^

StO2 (%)

71.1±0.9

72.6±0.1

57.7±1.7 *

68.5±0.8*#

74.4±0.8 *#^

MAP (mmHg)

n/a

77.9±0.5

91.9±5.1*

83.2±0.2 *#

84.8±0.2 *#^

Pulse Rate
n/a
63.5±0.3
82.7±0.2*
69.3±0.5*#
62.0±0.4* # ^
(BPM)
Blood flow data represents both local (rBF/BF) and strain gauge (SGBF) blood flows. Reported as
mean ± standard error. * denote statistical difference (p < 0.05) from baseline values as
determined by t-test, # represents statistical difference from end-exercise values by the same test
and level of significance, and ^ denote significance between 1-minute recovery and end-recovery
values.
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4.3

Gastrocnemius Translation and Exercise Hemodynamics Discussion

4.3.1 Calibration of Absolute Measurement and Cross Validation with
Strain Gauge

The use of VO to calibrate DCS flow indexes is based on the presumption that
resting blood flow is proportional to the diffusive motion of erythrocytes in tissue.
By assuming a relatively steady state resting blood flow, the initial normalized
value of αDB (100% of a 30-sec mean) is ascribed a perfusion value equal to the
calculated arterial inflow via the VO protocol. For such a calibration to be
trustworthy, one must have some guarantee that the measurement protocol is
stable and that the vasculature is in a truly resting state. It is also important that
the VO not induce large changes in local or systemic hemodynamics. This
assumption is borne out experimentally with local effects observed to recover
within one minute following the venous occlusion [14, 22, 28, 32].
For oxygen consumption rate calibration via arterial occlusion there are also
several underlying conditions which are required for validity of the measurement.
The first is that, generally speaking, since the venous compartment hold the
greatest volume of blood, oxygenation values reflect a weighting toward the
oxygenation of hemoglobin located in the post capillary vessels[29]. This
distribution is not allowed to change or the compartment ratio of venous to
arterial blood (γ, review chapter 2.4) may change and this alters the calculation of
oxygen extraction. The NIRS measurement of tissue StO2 is then safely assumed
to represent muscle tissue O2 saturation following oxygen extraction. This
assumption is what allows investigators to use arterial saturation and tissue
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saturation to make an artio-venous difference relation necessary for the
calculation. Microvascular blood flow is not as simple as entry, residence, and
outflow, however, as the system (depending on physiological necessity) is capable
of shunting the capillary beds or recirculating blood. However, the spatial
averaging of chromophore concentrations by NIRS results in overall tissue O2
saturation that is insensitive to such behaviors. The second major assumption is
that once the pressure cuff reaches full pressure, the blood inside the compartment
is theoretically isolated and therefore THC should remain constant, while any loss
of saturation is due to consumption by the tissue. In practice it is observed that
this is not strictly so, but is true enough to be valid for short durations[12, 14, 20,
61, 63].
NIRS oximetry in general contains a confounding variable in muscle tissue
due to the presence of the spectrally identical, single O2 binding chromophore
myoglobin. Myoglobin effects on NIRS oximetry is discussed heavily elsewhere
but suffice it to say that the much higher oxygen binding affinity of myoglobin
and myoglobin containing a single oxygen binding site limits the influence of
myoglobin desaturation to detected signals. Only once desaturation had reached a
sufficient point to decrease the tissue blood bound O2 to myoglobin bound O2 to
somewhat extreme levels[15,23,28,29].
Calibration protocols were successful in producing venous occlusions and
arterial occlusions that could be used to calibrate the relative blood flow and
oxygen consumption rate measurements made during the exercise protocol.
Initial blood flow measurements within each individual were consistent for each
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VO but varied widely between subjects. Such variability has been noted
throughout literature documenting blood flow and comes as no surprise to us[12,
63, 65, 84, 88, 89]. Despite the variations we found good agreement with
literature in both reported trends and actual values of calibration blood flow as
well as in other hemodynamic parameters (Figures 26 and 28, Tables 8 and 9)
Initial values for hemoglobin concentration, oxygen saturation, oxygen
consumption rate, blood flow, etc. were all well within normal physiological
norms[12-14, 17, 31, 54, 61, 63, 83]. Cross validation of our local optical flow
measurements with more global limb blood flow obtained via SGVP proved
successful with there being a good correlation between mean baseline flow values
obtained using the two methods (Figure 26). This agreement was lost in post
exercise strain gauge measurements, due largely to the great standard deviation
between subject blood flow responses to exercise with regards to both local and
limb measurements of flow (Figure 28, Table 9). Thus our aim of cross validating
DCS calibrated flow against strain gauge flow is met under resting conditions but
not during exercise.
There exists a possible systematic underestimate of V̇O2 that is related to
arterial leakage during arterial occlusions. Some subjects experience a small
increase in THC which can be attributed to an oxyhemoglobin concentration that
is not decreasing as rapidly as deoxyhemoglobin increases. Such microvascular
leak would decrease the slope of ([HbO2]-[Hb]) and thus the V̇O2 would be
underestimated, (see Figures 23 and 26). The VOs measured by strain gauge and
NIRS produced very similar and highly correlated changes in volume (Table 8).
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Local effects due to the occlusion series were transient and fully recovered within
5 minutes of recovery and with little drift between calibration and the initial
baseline for exercise (Figure 23 and Figure 27, Table 9). Minimal local
hemodynamic effects following this calibration protocol are a necessity to its use
since we cannot risk deviating the initial physiological conditions from baseline
prior to a measurement. This is to reduce the risk of weakening our ability to
distinguish exercise responses from unintended perturbation of the system during
calibration and MVIC tests.
The 5-minute minimum time between calibration/MVIC protocols and
beginning of baseline for exercise is used to reduce such possibility. This time
was deemed satisfactory given that prior investigations used 5-minute resting
periods between AO and exercise protocols or sometimes trials between
exercises[17, 31, 65].
The primary objective of this study however was to transfer the techniques
previously applied to the forearm to the lower limb muscles[20]. This included
ensuring that skin fold thickness and penetration depth were such that we could
get adequate signal. This proved to be the case with all subjects having ATTs
measuring less than 8 mm, most of which were closer to 7 mm, which places the
superficial muscle layer well within the ~13 mm envelope of a 2.5 cm S-D
separation set up[10, 32, 72, 90].
One parameter which possessed a potent influence was subject posture. The
lower perfusion pressure of the supine posture produced a substantially greater
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effort for subjects than did the sitting posture which has great implications on the
ability of PAD patients to perform such protocols[90]. Our original intent was to
perform seated protocols but changed to supine since there is a greater pool of
literature available for this posture; most notably the study performed by Bauer et
al in 2007 which had both PAD and age matched controls using a very similar
measurement methodology to ours consisting of measuring oxygenation with a
NIRS spectrometer during supine plantar flexion exercise protocols, but with the
notable exception that they measured blood flow via post exercise SGVP venous
occlusions[54]. This means that the Bauer study did not measure blood flow
continuously and only measured muscle tissue oxygenation (StO2), not
metabolism (V̇O2)[54]. Still the study served as a basis of comparison between
our measurement/exercise methodology and that of already accepted techniques.
However, future PAD study should use the seated posture to reduce the stress on
compromised vasculature of patients and make the study more closely resemble a
physiologically normal scenario (subjects will be more likely to be
sitting/standing than fully reclined).
4.3.2

Hemodynamic Profiles During Exercise

Exercise results of this study proved fruitful in that the combined NIRS/DCS
system, coupled with a finger plethysmograph, was able to capture a very broad
range of hemodynamic parameters noninvasively and continuously during
dynamic exercise. The author is aware of no other studies that demonstrate such
capability and this could mark the first noninvasive examination of absolute
values for all of these parameters throughout such a protocol in the
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gastrocnemius. Mean subject hemodynamic and metabolic changes due to
exercise parallels other similar study responses, see Table 10[13, 54, 65, 83, 84,
88]. A broad range of values exists in literature for both BF and V̇O2 depending
largely on how BF is measured. Such variation in methodology makes direct
comparison of outcomes difficult but allows us to examine trends. Of particular
import is the apparent rapidity of microvascular increases in blood flow, oxygen
consumption rate, tissue desaturation, as well as systemic responses. All of these
parameters increase dramatically within a few seconds of exercise and a full
hemodynamic plateau is reached within two minutes of 30%MVIC plantar
flexions. Exercise data collection gating successfully removed motion artifacts
during the protocol, preserving the quality of blood flow and metabolism optical
data (see Chapter 2.5 for reminder of gating algorithm). Post exercise changes are
likewise very rapid, being mostly complete within the first minute and the system
seems to impose a demand for high temporal resolution measurement methods
(Figures 27 and 28, Table 9).
The extent of absolute flow increase is more than 2 fold for most subjects,
ranging from a 0.44 ml/100ml tissue/min minimal responder to 3.76 ml/100ml
tissue/min. However, absolute resting baseline is not correlated with the
magnitude of exercise as some subjects with the highest initial absolute blood
flow had only mediocre relative increase (130-160%). Relative increases in V̇O2
are about 100% greater than those of BF and this is in line with literature reported
increases of oxygen extraction for metabolically stressed muscle[16, 54, 84, 88].
Initial mean V̇O2 was found to be 0.06 mlO2/100g tissue/min on average with
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ranges from 0.01 to 0.14 mlO2/100g tissue/min and typically increased much
more (100%) than BF from 0.02 to 0.39 mlO2/100g tissue/min, a pattern typical
for fatiguing exercise[31, 64, 65, 88]. Oxygen saturation exhibited, for the most
part, a substantial decrease, falling from initial 2-minute means of 70-75% to end
exercise plateaus of 55-50%. These response time courses and extents are
comparable to those of other similar studies using NIRS to measure oxygenation
[54, 84, 88]. The variation of response is not unusual for exercise and accents the
necessity for large subject populations in these kinds of studies.
Table 10. Comparison of Baseline and Exercise Values from Literature
Study

Methods for Resting BF
Exercise BF
Exercise V̇ O2
Resting V̇ O2
Measuring BF, (ml/100ml/min) (ml/100ml/min) (ml O2/100g/min) (ml O2/100g/min)
VȮ 2

Henry 2014,

0.88 ± 0.4;
NIRS VO;
SGVP,
1.13 ± 0.6
NIRS AO
(n = 10)
SGVP, (n=8)
~3

^Baur 2007
[54]
**Boushel
2000 [64]
*Casavola
2000 [14]

*Van
Beekvelt
2001 [65]

^Kooijman
1997 [13]

^Egena 2005
[89]

SGVP,
NIRS/SGVP,
(n=7)
NIRS VO,
multiple
measures on
single subject
NIRS VO;
SGVP,
NIRS AO;
NIRS SGVP,
(n=26)
NIRS VO,
NIRS AO,
(n=15)
SGVP, (n=12)

2.6 ± 0.3

1.87 ± 09;
5.13 ± 1.0

0.05 ± 0.03

0.17 ± 0.01

~26
44 ± 7
0.23 ± 0.07

6.6 ± 1

0.40 ± 0.10
0.04 ± 0.02
0.9 ± 0.45;
2.06 ± 0.70
0.11 ± 0.02;
0.15 ± 0.06
0.68
(0.54-0.97)

1.36
(1.12-1.64)

~3

~18

0.02
(0.01-0.03)

0.04
(0.02-0.05)

*Data presented as mean ± std, ** data presented as mean ± std error, ^ data presented as figure
(extrapolated from data but not explicitly stated in text). Due to the complexity and variety of
these studies a “;” is used to indicate two methods of measuring a single parameter (reported top
first bottom second) and a “,” used to indicate the separation of parameters measured.
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Strain gauge plethysmography BF measurements, with end exercise values
ranging from 2.5 ml/100ml tissue/min (2X mean baseline) to 12.8 ml/100ml
tissue/min (12X mean baseline), were of much greater variance than local optical
measurements; end-exercise data show 270% (SGVP) mean standard deviation
compared to 30% (DCS) mean standard deviation. The extreme variation of
SGVP end-exercise values and issues related to the methodology lead us to
conclude that SGVP should only be used to evaluate limb resting flow and cannot
be used to accurately assess the behavior of local microvasculature. There could
be a nonlinear relation between local muscle blood flow and whole limb blood
flow. Indeed, the two should not be expected to have a strictly linear relation as
the factors that govern microvascular flow are different in many ways than those
that govern whole limb flow[13, 26, 27, 85]. Examples of this include the
sympathetic vasoconstriction of vascular beds in non working muscles while
working muscles vasodilate. Whole limb and working muscle blood flow may
increase but microvascular flow in the non working muscles is decreased. Such
difference in methodology, observed wide variances for end exercise strain gauge
BF, and a lack of correlation with end exercise rBF, as well as the necessary
temporal delay between end of exercise and VO, makes end exercise blood flow
measurements by strain gauge non optimal.

Few studies make extended measurements of recovery periods following
exercise and those that do rarely report this data as time series. Such omission
makes it difficult to assess the pattern of hemodynamic recovery following
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metabolic challenge. Our data show a very pronounced post exercise increase in
most parameters. The only parameter to reach pre exercise values significantly
was pulse rate. MAP, BF, V̇O2, and StO2 all remained elevated throughout
recovery (see Chapter 4.2.2). Sustained significant flow elevation post exercise is
typical of rigorously exerted non athletic subjects and agrees with the results
found in the few studies that included a prolonged recovery measurement of blood
flow[84, 88, 91]. From this it can be definitively concluded that recovery from a
strenuous exercise protocol can be quite prolonged in the muscle tissue.
These results highlight the importance of the previous baseline shift study as
this time period would be highly susceptible to the influence of a gradual shift in
blood flow (which would also affect the derived oxygen consumption rate).
Furthermore, the increases found during the baseline study were of approximately
the same magnitude and time course as the post exercise effects meaning that the
two would be indistinguishable from each other had we not taken steps to
alleviate the probe pad influence.
Total Hemoglobin concentration sharply decreased at the onset of contraction.
This decrease seems to be more predominant in oxyhemoglobin than
deoxyhemoglobin producing a steep desaturation curve that is consistent with
other literature[54, 84]. If the initial contraction of the muscle causes a shift in
overall hemoglobin distribution of the muscle that is not resolved before
observation during the resting periods then there may be a change in γ (see
chapter 2.4) for which it is necessary to account[16, 17, 54, 92]. Previously our
lab had calculated that this change should be small enough to not present a
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significant effect and could be ignored, with this view being also supported by
literature [16, 92].

4.4

Gastrocnemius Translation Study Conclusions

Techniques developed by previous studies in the forearm were successfully
translated to measurement of the lower limb, with attention to posture, contraction
frequency, calibrating occlusions, and attachment of the optical probe. Success in
calibration was evidenced by having obtained baseline absolute values for BF and
V̇O2 that were comparable to those found in previous studies (see Tables 9 and
10). Cross validation of NIRS VO BF measurements at rest with SGVP was
positive with SGVP BF being comparable in magnitude and correlated to optical
values. This agreement was lost during exercise. Data were of good quality with
fairly low variance (mean standard deviation of 30%, compared to over 200%
changes in relative values for BF and V̇O2 at end exercise, the most unstable
period) for subjects indicating that attachment protocols and data gating during
exercise were functioning as intended.
Exercise protocols successfully induced physiological challenge in healthy
control subjects and measurements during exercise were free of motion artifact
due to implementation of a gating algorithm produced previously[20]. These
exercise trends were also of similar profile to those of similar exercise studies,
inasmuch as our continuous optical DCS measurements can be compared to
profiles using SGVP and Doppler ultrasound to assess flow. Oxygenation data
clearly agree with tissue saturation profiles in literature demonstrating the
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effectiveness of this exercise protocol to induce challenge of the muscle. Systemic
cardiovascular response also suggested effectiveness in challenging subjects and
induction of whole body response to lower leg exercise, making this protocol a
sound investigation of exercising hemodynamic response in healthy subjects.
Overall, we have generated a ready pool of data for young healthy control
subjects against which we can compare future studies, satisfying both of the
primary objectives of this study. Using these methods we may begin
investigation into PAD subject populations.
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CHAPTER 5: PAD PILOT INVESTIGATION OF HEMODYNAMIC
RESPONSE IN COMPROMISED VASCULATURE
The aim of this pilot study was to explore the feasibility of the calibration
and exercise methods discussed in Chapter 4 to a small population of PAD
patients, as well as healthy control subjects.

PAD in particular, being a

perfusion disorder, stands out as being a disease about which our technology may
be able to provide clinically relevant data. By using the calibration and
dynamometer gated exercise protocol we may be able to assess local
hemodynamic, metabolic, and systemic cardiovascular response differences in
PAD patients as compared to healthy ones. But in order to pursue this research it
was first necessary to test a small sample group and identify possible problems or
inadequacies in our instrumentation/methodology. Toward this end we measured
2 patients, of different levels of claudication (one resting pain, one activity
induced ischemia), and 3 healthy subjects using the protocol outlined in chapters
4.1.2 and 4.1.3, with the modification of using a sitting posture. This sitting
posture is less hemodynamically demanding and so was judged to offer less
chance of patients having an ischemic attack during the protocol and failing to
complete it, or being unduly pained (which presents both ethical and
physiological variability challenges).
5.1

PAD Pilot Experimental Protocols
In order to provide significant metabolic challenge to the lower extremity

muscle tissue and vasculature, for the purpose of determining the functionality of
such under stress, we decided to perform a sub-maximal plantar flexion exercise
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protocol. The protocol was to be performed by a small pilot population of two
PAD patients (recruited via collaboration with vascular surgeon Dr. Eleftherios
Xenos, of the Kentucky Clinic) and three healthy control subjects. Subjects were
recruited on volunteer basis gave consent, after being informed of the protocol to
be performed, on approved IRB consent forms. Three control ages were 26, 35,
54years, while PAD patients were of similar ages, at 62 and 64. Patient ages were
comparable to the ages (64 ± 3 PAD) listed in Bauer et al 2007[54]. Healthy
control subjects were taking no known medications for cardiovascular disorders
and had no known health conditions before the protocol was started but one
healthy control subject (aged 35) did appear to have pre-hypertension. Both PAD
patients were hypertensive but did not notify us as to any treatment medications
such as vasodilators or diuretics. PAD Patient 1 was wearing a compression boot
on his left (most claudicant) leg and reported resting pain in this leg, while the
other patient had no pain at rest. This indicated that Patient 1 was in a more
advanced disease state than Patient 2.
Preliminary clinical tests performed during assessment for treatment
demonstrated notable differences between patients using similar continuous wave
Doppler with segmental pressure exams, with the notable difference that one
patient (patient 2) underwent a treadmill walking test (4 minutes, 2 mph, 12%
incline). The ankle/brachial pressure index (ABI) is used to assess the degree of
claudication in patients by determining the relative decrease in pressure in the
lower limb as compared to the contra-lateral upper limb (ABI= Pankel/Pbrachial).
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Generally, the scores greater than 0.95 to 1 indicate a healthy un-occluded limb
while scores of less than 0.9 indicate increasing levels of claudication.
PAD patients were to be delivered to the test room via wheelchair to prevent
claudicating symptoms and muscle fatigue before the protocol began.
Subjects/patients were then asked to sit in an adjustable chair with their feet in a
dependent (declined) position, as opposed to elevated, in order to increase
perfusion pressure in the lower legs (comparing Figures 22 and 30)[90]. The
instrumentation, optical probe, and data collection/processing were the same as
those used to assess healthy control hemodynamics during the translation study
detailed in Chapter 4.1, as were the baseline absolute hemodynamic calibrations
(Chapter 4.1.2) and exercise protocols (Chapter 4.1.3) used for inducing
hemodynamic challenge in this study. The entire protocol set up is illustrated in
Figure 29.
Resting relative blood flow during calibration occlusions was not saved for
healthy subjects, online data was used to evaluate successful occlusions for these
3 healthy subjects but was later recorded for PAD patients to better evaluate
occlusion success and is now standard practice for all protocols.
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a)

b)

Figure 29. PAD Pilot Measurement Set-up and Probe/Leg
Position
Figure 29a shows a full protocol set up during calibration phase. After calibration and MVIC test
a finger plethysmograph is placed on the right hand middle digit to record systemic parameters.
The device can cause bluing of the finger and mild discomfort over time and so is not used
during calibration. 1) shows the placement of the optical probe (viewed more closely in figure
20) over the medial gastrocnemius muscle belly. ATT are taken from this same location. 2)
Shows the hybrid FD-NIRS/DCS optical system. The operating systems for both devices are on
separate computers and are controlled separately except for TTL signaling during data collection.
3) This is the dynamometer head and footplate which controls the subject work output during
exercise, just off-screen is the dynamometer operation screen (at patient’s eye level) which
contains the visual metronome and protocol control settings. 4) The occlusion thigh cuff is shown
here in its typical placement, again in a closer view in Figure 29b, as is the optical probe.

5.2

PAD Pilot Protocol Results

5.2.1

Hemodynamic Profiles During Calibration Occlusion Protocols

Resting ABIs were within normal limits with patient 1 having a 1.23 (left) and
1.2 (right) score while patient 2 had a 1.0 (left) and 0.92 (right) score. Patients
were deemed by this examination to be lacking evidence of significant arterial
occlusive disease at rest. The treadmill test revealed patient 2 to have nonrecovering scores of 0.3 (severely occlusive) for both legs and indicated
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significant arterial occlusive disease and substantial insufficiency with exercise.
Given the patient histories of diabetes and high blood pressure the high normal
scores for patient 1 are indicative of arterial hardening and incompressible
vasculature typical of diffusive PAD. Thus the resting ABI test should always be
accompanied by an exercise test for PAD examination to rule out false positives
caused by such contributing disease states.

Table 11. Subject Demographics and Resting Optical Baseline
Values
Subject Demographics and
Key Protocol Values
Age (yrs)

Healthy Control

PAD Patients

35, 54, 26

62, 65

Skin Fold Thickness (mm)

6.5, 6, 7.5

8, 7.5

MVIC (N∙m)

91, 53, 72

19, 45

Mean Power (W)

13.7, 8.0, 10.7

2.9, 6.8

Baseline StO2 (%)

70, 65, 68

55, 60

Baseline Optical BF
(ml/100g/min)

0.43, 0.74, 0.51

0.07, 0.36

With only 3 controls and 2 patients’ data, not age matched, conclusions are
based on and emphasize observed trends; this data is not definitive and should
only be considered from the perspective of showing the potential of hybrid diffuse
spectroscopy to observe the healthy and patient population trends. MVIC for
healthy subjects was generally greater than patients, with corresponding powers
of exercise being higher. This suggests that there is a strength gap between
healthy subjects and PAD patients but without more subjects this is a highly
preliminary assessment.
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The calibration protocol for healthy controls proceeded normally and was
consistent in trend for all subjects (illustrated in Figure 30). Individual values for
initial blood flow and oxygen consumption rate varied widely but were within
ranges of previous studies, at 0.43 to 0.74 ml/100ml tissue/min for blood flow and
0.015 to 0.11 mlO2/100g /min for oxygen consumption rate and no artifact was
noted during the occlusions/fitting estimates (Figures 30 and 31, Table 12). Note
that rBF for healthy controls during calibration were not recorded. The success of
the occlusions is demonstrated by normal increases in THC during VO, and
mostly stable THC during AO accompanied by divergent Hb (increase) and HbO2
(decrease) as seen in Figure 30.
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Figure 30. Calibration Hemoglobin Time Courses for Healthy
Control Subjects
Descending order: Deoxy, Oxy, and THC, and StO2. Occlusion periods are shown by arrows (to
account for slight differences in occlusion time periods) with small arrows representing VO, and
large arrows the AO.

Figure 31. Sample Healthy Control Subject Occlusions with
Calculated Resting Blood Flow and Oxygen Consumption Rate
VOs (top panel) were largely consistent and produce a physiologically normal resting muscle
blood flow. Success of the arterial occlusion is observed in the immediate decrease in [HbO2]
compared to [Hb] and the typical oxygen consumption rate value calculated.
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PAD patient calibrations were met with mixed success. While venous
occlusions and initial blood flow measurements seemed to be successful, no
absolute V̇O2 values are available for PAD subjects. This is due to arterial
occlusions being unsuccessful in these subjects, as can be observed both by the
hemoglobin concentration (non diverging [Hb] and [HbO2]) and by the additional
observation of non zero relative blood flow during occlusion (Figures 32 and 33,).
Initial oxygen saturation values for healthy subjects ranged from 65 to 70%
compared to PAD patients who had saturations of 60% and 55% at rest (Figure 30
and Figure 32, Table 11). PAD patient resting blood oxygen saturations were
lower than all healthy controls. The resting oxygen saturation of PAD patients are
comparable to the end arterial occlusion values of the healthy controls, suggesting
that resting patient muscle is in a substantially hypoxic environment (Figure 30
and Figure 32). Neither patients’ hemoglobin nor oxygen saturation values
returned to rest within 5 minute recovery periods, indicating an observable lack of
recovery in PAD patients compared to healthy controls. Calibration BF values for
healthy subjects ranged from 0.74 to 0.43 ml/100ml tissue/min, while patients had
widely different values of 0.07 and 0.36 ml/100ml tissue/min, both of which were
values lower than even the smallest of the healthy control values.

111

Figure 32. Calibration Hemoglobin Time Course for PAD
Patients
Descending Order: [Hb], [HbO2], and THC, StO2, and rBF. Vertical lines denote three VOs,
followed by a single AO time period. Subjects’ responses to occlusion were markedly different,
with Subject 1 possessing a highly muted blood flow and lower resting oxygen saturation than
Subject 2. Neither subject could produce a successful arterial occlusion, as indicated by the
oxygenated and total hemoglobin responses (second and third panel from the top). 250 mmHg
pressure was used in Subject 2 AO but Subject 1 could not withstand this pressure (due to pain).
rBF data show that rBF in Subject 1 is not greatly affected by this pressure (250 mmHg).
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Figure 33. Sample PAD Patient Occlusions with Calculated
Resting Blood Flow and Oxygen consumption rate
VOs (top panel) were successfully performed and with reasonable outcome. The AO (marked by
vertical lines) displays a notable delay from onset of occlusion to apparent decrease in difference
between HbO2 and Hb. This is evidently due to the inability to fully restrict arterial inflow (see
Figure 33) which causes a large underestimate of oxygen consumption rate despite relatively
normal (low) blood flow. This calculated oxygen consumption rate value is not deemed to be
acceptable for use in estimating resting tissue metabolism.

5.2.2

Hemodynamic Profile During 30% MVIC Plantar Flexion Protocols

Lacking a robust statistical relevance in this data set, individual data are
presented and time series trends/mean values are presented, for the sake of this
pilot study. A note on results from the first PAD patient should be made in that
the subject was unable to maintain the correct rhythm initially and thus data were
initially unstable during exercise (as indicated by large deviations) until coached
into the correct rhythm for the appropriate duration of exercise at the 0.5Hz
frequency.
Hemoglobin concentration changes differ between the groups with PAD
patients exhibiting a muted change in all hemoglobin concentrations compared to
healthy control subjects. All subjects exhibited an initial increase in oxygen
saturation at the onset of exercise and this is observable to be related to the initial
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clearance of [Hb] compared to desaturation of [HbO2] (Figures 34 and 35). This
trend has been observed in other studies under similar conditions[31, 54]. The
observed hemoglobin time course is consistent with previous results for plantar
flexion exercise (Chapter 4).
Exercise values (see Table 12) for healthy controls were generally robust,
increasing a mean (787.4%, 609.5%, and 219.9% respectively from baseline.
These healthy profiles followed the same trend observed in Chapter 4 healthy
control exercise of rapid initial increase, plateau, and rapid decrease following the
end of exercise (see Figure 34). PAD patients demonstrated sharply different
responses from one another with the claudicant patient rBF increasing by a mean
216% while the less severe patient rBF increased to a mean 710% (Figure 35,
Table 13). rV̇O2 values were different in trend between healthy and patient
populations, with mean exercise rV̇O2 being typically lower than mean exercise
rBF (89.8% higher, 125.9% lower, and 51.5% lower) for control subjects 1
through 3 respectively (Table 12). PAD patients had mean exercise rV̇O2 values
that were only 5.0% lower (in the resting claudicant patient 1) and 26.4% lower
(in the mild PAD patient 2) than end exercise rBF (Table 13). This suggested a
larger increase in oxygen extraction for those PAD subjects with a lesser blood
flow. Absolute blood flow seemed to be greater in most of healthy controls (3.88,
5.34, and 1.69 ml/100ml tissue/min) than in patients (0.14 and 2.56 ml/100ml
tissue/min). Particularly notable was the difference between the claudicant PAD
patient profile and the rest of the subjects (Figures 34 and 35, Tables 12 and 13).
Oxygen saturation trends were greatly divergent however with healthy subjects
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exhibiting desaturation during exercise while patients possessed very little
change, even increasing during exercise (Figure 34 and 35).
Recovery was incomplete for most subjects in all parameters except pulse rate,
which tended to not be significantly different from baseline (Table 12 and 13).
The 1st minute and 15 minute recovery values were calculated and indicated rapid
recovery but a sustained super baseline level for both local parameters and
systemic MAP persists, similarly to the results of chapter 4 protocols.
The systemic data (pulse rate and MAP) for both populations show a response
with a trend of increase during exercise. MAP data is, however, notably unstable
(see Figure 35) for both patients, which may indicate some plethysmograph
instrumentation errors. The two patients are clinically hypertensive as is one of
the control subjects (as defined by a resting MAP >105). These data are not
stable or consistent enough on which to base any sound conclusions, given the
instability in the instrument for observation of the PAD patients.
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Figure 34. Healthy Control Subject Hemodynamic Profiles
During Dynamic Exercise
Descending order: [Hb], [HbO2], and THC, StO2, rBF and rV̇O2 coaxially, pulse rate, and MAP.
Exercise periods are denoted with a black arrow. Note here that the oxy saturation increases at
onset of exercise before decreasing, in contrast to the slight increase followed by plateau of PAD
subjects.
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Figure 35. PAD Subject Hemodynamic Profiles During Dynamic
Exercise
Descending order: [Hb], [HbO2], and THC, StO2, rBF and rV̇O2 coaxially, pulse rate, and MAP.
Exercise periods are denoted with a dotted black arrow for subject 1(due to inability to retain
correct rhythm, initially) and solid for the second patient. Data shown are the filtered individual
time series, filtration is done as previously described. Of note is the apparent lack of decrease in
oxygen saturation and lack of separation between relative blood flow and oxygen consumption
rate curves.
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Table 12. Summary for Healthy Control Subject
Hemodynamic Values
Time Period Mean
Baseline rBF (%)

Control 1
106.3±30.8

Control 2
99.9±33.8

Control 3
106.7±49.7

Baseline BF
(ml/100ml/min)
Baseline rV̇O2 (%)
Baseline V̇O2
(mlO2/100g/min)
Baseline MAP (mmHg)

0.46±0.13

0.75±0.25

0.55±0.26

111.9±32.0

75.0±25.3

108.6±51.2

0.045±0.013

0.015±0.005

0.098±0.046

119.2±1.0

84.6±2.6

92.0±3.8

Baseline Pulse (BPM)

60.4±0.9

68.0±2.2

60.2±0.9

End Exercise rBF (%)

893.7±121.8*

709.4±201.9*

326.6±102.1*

End Exercise BF
(ml/100ml/min)
End Exercise rV̇O2 (%)
End Exercise V̇O2
(mlO2/100g/min)
End Exercise MAP
(mmHg)
End Exercise Pulse
(BPM)

3.88±0.53*

5.34±1.52*

1.69±0.53*

983.5±146.6*

583.5±165.3*

275.4±86.5*

0.393±0.059*

0.117±0.033*

0.248±0.078*

129.6±0.4*

96.8±0.3*

106.5±4.0*

63.7±0.5*

66.3±0.6*

72.2±0.8*

Recovery 1 min rBF (%)

398.7±260.7*#

239.7±177.4*#

160.5±62.0*#

Recovery 1 min BF
(ml/100ml/min)
Recovery 1 min rV̇O2
(%)
Recovery 1 min V̇O2
(mlO2/100g/min)

1.73±1.13*#

1.80±1.34*#

0.83±0.30*#

444.0±293.9*#

201.8±147.8*#

143.3±58.3*#

0.178±0.118*#

0.040±0.030*#

0.129±0.053*#

Recovery 1 min MAP
(mmHg)

123.9±1.97*#

95.1±0.7*#

94.2±3.6*#

Recovery 1 min Pulse
(BPM)

61.1±1.9*#

65.2±0.2*#

64.0±3.9*#

End Recovery rBF (%)

101.5±37.1#

145.3±46.3*#

134.9±50.9*#

End Recovery BF
(ml/100ml/min)
End Recovery rV̇O2 (%)

0.44±0.16#

1.09±0.35*#

0.70±0.26*#

107.2±39.1#

103.6±32.9*#

136.1±51.1*#

0.042±0.016#

0.021±0.007*#

0.123±0.046*#

End Recovery MAP
(mmHg)

131.0±1.5*#

88.0±2.4*#

94.3±0.9*#

End Recovery Pulse
(BPM)

64.2±0.4*#

67.1±2.0*

59.2±0.4*#

End Recovery V̇O2
(mlO2/100g/min)

Data presented as mean ± std for each individual. These were calculated from 3 mins baseline
data (150 frames), the final minute of exercise data (20-30frames), the first minute of recovery
data (50 frames), and the final minute of recovery data (50 frames). Significance (p < 0.05) is
represented by * for comparing against baseline, and # for significance from end exercise. Raw
time series data were selected according to data frame time stamps to ensure accurate time points.
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Table 13. Summary for PAD Patient Hemodynamic Values
Time Period Mean
Baseline rBF (%)

PAD 1
112.4±50.7

PAD 2
106.4±37.3

Baseline BF (ml/100ml/min)
Baseline rV̇O2 (%)

0.07±0.03

0.38±0.13

111.2±49.9

107.5.0±37.9

Baseline MAP (mmHg)

97.9±5.2

88.7±5.9

Baseline Pulse (BPM)

74.3±2.0

57.0±1.6

End Exercise rBF (%

215.7±143.3*

709.7±219.7*

End Exercise BF
(ml/100ml/min)
End Exercise rV̇O2 (%)

0.14±0.09*

2.56±0.79*

210.7±144.0*

683.3±208.3*

End Exercise MAP (mmHg)

115.9±0.7*

110.2±1.6*

End Exercise Pulse (BPM)

73.5±0.3*

64.9±0.3*

Recovery 1 min rBF (%)

136.5.7±132.9*#

165.0±155.5*#

Recovery1min BF
(ml/100ml/min)
Recovery 1 min rV̇O2 (%)

0.09±0.09*#

0.60±0.56*#

132.7±128.6*#

165.5±155.0*#

Recovery 1 min MAP (mmHg)

113.9±0.6*#

91.6±6.8*#

Recovery 1 min Pulse (BPM)

72.8±1.0*#

58.4±2.7*#

End Recovery rBF (%)

98.6±37.1#

151.0±74.9*#

End Recovery BF
(ml/100ml/min)
End Recovery rV̇O2 (%)

0.06±0.04#

0.54±0.27*#

103.5±69.7#

146.8±72.8*#

End Recovery MAP (mmHg)

116.0±1.1*

102.6±2.1*#

End Recovery Pulse (BPM)

74.0±0.8#

56.4±0.8*#

Data are presented as mean ± std for each individual. These were calculated from 3-minute
baseline data, the final minute of exercise data, the first minute of recovery data, and the final
minute of recovery data. Significance (p < 0.05) is represented by * for comparing against
baseline, and # for significance from end exercise. Raw time series data were selected according
to data frame time stamps to ensure accurate time points. Due to failure to adequately occlude the
limb V̇O2 could not be determined for these patients.
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5.3

PAD Pilot Protocol Discussion

5.3.1

Calibration Protocol

The results of this pilot indicate that there seems to be a combination of factors
involved with PAD. The most obvious parameter is the reduced resting oxygen
saturation. The baseline oxygen saturation measured in these two subjects was
below or near those reached during the end of 3 minutes arterial occlusion or at
the end of exercise for healthy control subjects (see Table 11, Figure 30 and
Figure 32). This disparity clearly indicates that PAD is an ischemic condition,
which is supported by most PAD literature [3, 13, 55, 93]. The ability of NIRS
instrumentation to observe difference in baseline oxygen saturation is a positive
sign for future studies being able to discern possible PAD tissue perfusion effects
at rest.
Optical venous occlusion measurements were able to calibrate initial blood
flow for the DCS instrument in both healthy and patient subjects. The patients,
particularly the resting claudicant, had lower baseline BF than healthy subjects.
We were unable to calibrate our rV̇O2 measurements in PAD patients since we
could not successfully induce a total AO in either subject. The claudicant patient
was unable to tolerate arterial occlusion pressures due to claudication pain. The
second patient, even at 250 mmHg, could not sufficiently be occluded (see Figure
32) as to be able to assume an isolated compartment. As a result, both patients
exhibited marked arterial leakage (Figures 32 and 33) which invalidated the
calibration occlusion. Given the sensitive nature of later stage PAD patients and
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the likelihood that some future studies may attempt comparisons between pre and
post operative patients to assess successful reperfusion surgery, AO calibration
may not be feasible within this subject population. However, our recent studies
have shown that using a VO protocol can also estimate oxygen consumption rate,
which will be explored in PAD patients in the future[94, 95].
Baseline and calibration occlusion trends for absolute hemoglobin and relative
blood flow were observable for all subjects using the methods outlined in 4.1.2
and these were similar to those results found in chapter 4.2.1. Despite observable
indications that there may be a different StO2 trend during recovery from AO we
cannot say that such difference is positively confirmed, nevertheless the trends for
oxygen saturation between the two PAD subjects were consistent between each
other and are suggestive of tissue oxygenation effects due to PAD being possibly
quantifiable by NIRS spectroscopy.
Depressed tissue saturation and muscle strength is indicative of compromised
function in the gastrocnemius microvasculature for these patients. The PAD
patients we measured, especially the resting claudicant, were substantially weaker
than controls. Without more subjects no generalizations may be made about
control and patient populations strength however, and some literature indicates
that there may be no difference in strength for mild PAD[54]. It should be noted
that since healthy controls were not age matched the effect of age on all these
parameters cannot be evaluated and age matching would be paramount to
establish in a full scale study with MVIC used as a possible regression parameter
for predicting BF/V̇O2 response to exercise.
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5.3.2

Exercise Protocol

Following trends in previous studies, individual responses varied widely
between individuals but in the case of this protocol the responses were much more
robust for healthy controls. The large increases in rBF found in these subjects
(including both healthy subjects and a patient) compared to Chapter 4 responses
may indicate that postural perfusion pressure may be more potent than previously
assumed. As expected, the resting claudicant subject was unable to greatly
increase flow and appeared to fatigue before the end of the protocol as the
exercise flow response could not be maintained throughout the protocol. While
this exercise intensity may be applicable in the seated position, it would likely
prove too strenuous for severely claudicant patients or for patients measured in
supine.
The apparent increase in oxygen saturation at the onset of exercise is likely
attributable to a fluid shift since THC, HbO2, and Hb decrease initially but Hb is
preferentially removed indicating venous clearance by the muscle contraction, a
similar trend is observed in forearm data reported by our lab[20]. The lack of
desaturation and overall hemoglobin profile in these subjects is different from that
observed in Chapter 4 protocols and requires more data to be conclusive but does
demonstrate potential for observing differential responses to exercise onset.
Relative oxygen consumption rate trends closely follow those of relative blood
flow for healthy controls indicating that these subjects have a flow dominated
increase in oxygen consumption rate as opposed to an extraction dominated one.
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These responses, at least for healthy control subjects, are in contrast to the
Chapter 4 protocol results in that V̇O2 nearly uniformly increased much more than
BF as would be expected of a metabolically challenging protocol. These
responses were consistent among patients with most subjects having an rV̇O2
unexpectedly close to rBF, but more data is required before this observation can
be assumed to apply to the general population. The ability to monitor both flow
and oxygen metabolism in comparison to one another may prove to be a potent
tool in determination of possible PAD effects on muscle oxygen utilization.
Pressure responses were similar to previous protocols in that there was a
distinct increase in MAP during the protocol and a decrease to a super baseline
pressure throughout the recovery period. Pulse rates are also consistent with
previous protocol results, recovering completely. Systemic parameters were not
greatly different compared to healthy controls, indeed the blood pressure profiles
were more similar than initially assumed and would not explain the differences in
exercise responses observed. Pulse rate and MAP were clearly elevated for all
subjects during exercise, except the claudicant who could not generate enough
effort to stimulate pulse rate response.
5.4

PAD Pilot Protocol Conclusions
Important for the purposes of this pilot, all subjects could complete the

majority of the protocols with the exception of arterial occlusions which require
re-evaluation for employment/stability in patient populations and may possibly be
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replaced by a venous occlusion protocol to calibrate resting oxygen consumption
rate.
Systemic and local hemodynamic profiles were generally in line with those
observed in supine healthy control exercise protocols sharing rapid changes at
onset/end of exercise with sustained hemodynamic elevation persisting
throughout the 15-minute recovery period, with the exception of the oxygenation
data discussed above. Of particular interest, it was found that there seemed to be
a different trend of response in healthy control hemodynamics while sitting
compared to supine. This might be due to the difference in hemodynamic
environments from supine to sitting posture and so much more data is required to
be able to draw meaningful comparisons between healthy control responses in
sitting vs. supine subjects let alone disease populations against healthy ones.
With such a small subject size we cannot verify the generality of these responses
but the overall similarity with previous studies and broadness of the
hemodynamic data that we were able to obtain is promising.
Overall, this pilot was successful in demonstrating the potential of a hybrid
flow/oximeter in observing and quantifying local muscle hemodynamics. The
protocol methodology proved mostly sound and was repeatable for 5 subjects.
While some questions pertaining to calibration, postural effects, and finger
plethysmograph reliability must be resolved the hybrid diffuse optical methods
and overall protocol design are ready for refinement to begin a broader set of
experiments. Future studies, with greater numbers of subjects may more
rigorously assess PAD hemodynamic responses based on these findings. Lastly,
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the normal range of ABI test values for the patients at rest clearly indicates need
for alternative means of detecting claudication and determining patient muscular
microvascular health. For the purposes of more clearly defining disease status in
future patient populations it would be preferable to use walking tests for all
patients to better ascertain the level of claudication of each patient. These may
then be used, in conjunction with our local measurements and exercise protocol,
to better quantify disease progression and regress data on the basis of
hemodynamic response versus clinical predictors.
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CHAPTER 6: LIMITATIONS, SUMMARY, AND PERSPECTIVES

6.1 Limitations of Optical Spectroscopy and Measurement Methodology
The limitations of diffuse optical techniques, particularly DCS, are
predominantly related to the light penetration depth into the tissue. Low power
NIR light sources and single mode detection fibers make for a maximal tissue
penetration depth of ~1.5 cm for DCS, depending on tissue absorbance and power
delivery to the tissue[31, 44, 96]. NIRS allows for the use of larger multimode
detector fibers and can collect oxygenation data in tissues up to ~3 cm deep[13,
31, 59, 64, 65]. The current penetration depth of DCS allows for examination of
the superficial skin and muscles but not deeper muscles and organs. The use of
bundled detector fibers greatly improves what signal we may obtain from these
tissues, even at greater depths[31-33, 41, 59].
Related to penetration depth is the inability of (especially DCS) optical signal
to reliably escape from large vessels. The high absorber concentration (blood
volume) of the veins and arteries means that optical probes positioned with large
vessels in the photon diffusion path length experience greatly reduced signal
amplitude resulting in the inability to correlate flow or determine tissue
oxygenation through these vessels. Probes should be positioned carefully to avoid
optical paths through such vessels. This disadvantage compensates by strictly
limiting our observations to microvascular flow.
Temporal resolution is dependent on correlation time, which is itself
dependent on signal strength. While each individual correlation curve calculation
is very rapid (~20 Hz or 50 ms per curve), these curves must be averaged to
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reduce noise[20, 33]. With low absorbance tissues (female muscle e.g., typically
exhibits a much greater signal to noise ratio as compared to male muscle tissue)
correlation averaging times may be decreased, increasing the ultimate sampling
frequency. Experimentally, it was general practice here for leg muscles to use
sampling rates of 1-2 Hz, which when coupled with oximetry, resulted in an
overall sampling rate of 1 Hz for every hemodynamic parameters (MAP, pulse
rate, BF, [Hb], [HbO2], THC, StO2, V̇O2).
The use of an optical probe secured directly to the tissue surface has its own
problems. Contact measurements are subject to introducing curvature errors due
to the flattening of soft tissue underneath the optical probe[96]. Sharply curving
surfaces, such as small limbs, alters the geometry of the probe/tissue interface
and, in the case of small tissue volumes, may induce spatial violations of the
semi-infinite boundary condition[96]. Contact probe pressure can also generate
substantial hemodynamic response in resting baselines and during exercise. The
reasons for this are explored in detail in Chapter 3.
Previously, a major limitation was that of motion artifacts. Changes caused by
motion may be observed in both NIRS oximetry and DCS, but DCS is influenced
in a particular way that makes it more susceptible to artifact. The ratio of
dynamic to static scatterers (α) is assumed to remain constant during
measurements reflecting at least short term stability in hematocrit. It is this
assumption that can lead to motion artifacts during measurements however.
When non-blood related cells move, light is scattered by these additional dynamic
scatterers e.g., muscle fibers and α is substantially increased. This causes a
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greatly overestimated flow index and its effects are noted in literature using DCS
methodology to observe muscle systems[16, 20, 44, 83]. Much of this artifact can
be avoided by careful protocol control and subject training. The restriction of
data collection to static phases of exercise allows a very near approximation to
continuous observation without loss of important data.
An exercise protocol specific problem was that it proved difficult for patients
and new subjects to adjust to the exercise timing. The pacing for contraction and
rest are crucial to collecting stable data and difficulties in proper timing result in
erratic data points (see PAD subject 1 exercise data, chapter 5.2.2). Also, some
questions arise as to how much MVIC tests and the familiarization period may
impact baselines. Extended responses to exercise indicate potential for elevation
between calibrating occlusions and exercise baselines, thus it may be preferential
to separate this procedure either by moving it to the start of the protocol and
requiring 25 to 30 minutes before calibrating occlusions, or doing it on a separate
day.
One of the challenges of measuring exercise hemodynamics is the large (and
widely documented) range of inter-patient variation. We noted substantial
differences in hemodynamic response even with strength normalization and age
matching, and this indicates that large populations will be required to assess the
diagnostic quality of these measurements. Statistical analyses demonstrate that
the results are more robust with 10 subjects providing a power of greater than
80% for baseline mean comparisons, rest vs. end-exercise comparisons, and endrecovery vs. baseline comparisons. rBF was used as a test variable for these
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studies and the results of power analysis extrapolated onto the remaining
variables, given the comparably large responses in these parameters with lesser
variance.
6.2

Summary of Research and Perspectives
Initial research aims of my study were to adapt the hybrid diffuse optical

techniques developed during previous examinations of forearm flexor muscles to
the lower leg muscles (gastrocnemius) during dynamic exercise. The intent for
this was to open a line of research into diseases of the vasculature and assessing
lower limb muscle tissue performance via hemodynamic and metabolic parameter
profiles during exercise.
Preliminary examinations and prior research indicated an unexpected baseline
shift during contact measurements and these had to be rectified before satisfactory
post exercise data collection or long duration protocols could be considered.
Baseline evaluation studies confirmed and characterized the baseline shift and
subsequent probe/protocol redesigns greatly stabilized the contact measurements.
In addition to greatly decreasing the measurement effect on the muscle tissue the
baseline studies confirmed the sensitivity of muscle microvasculature to
circumferential applied pressure. The baseline flow increase agreed in trend with
clinical assessments of the effectiveness of elastic bandaging for increasing
perfusion in the limb, a common treatment for vascular insufficiency related
disorders like PAD[69, 72, 73, 82]. By confirming the effectiveness of protocol
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redesigns in both the forearm muscles and gastrocnemius we were able to proceed
with lower limb studies.
Translating hybrid NIRS/DCS exercise measurement methods to the lower
limb involved first identifying accepted dynamic exercise protocols which could
be used in conjunction with our equipment and which could be controlled for
reproducibility. Dynamometer based plantar flexion exercises were decided upon
as was previously the case in forearm studies, for their commonality and for the
great control over exercise motions and associated data collection via the
dynamometer signaled positional gating algorithm developed previously. We
finally determined a comparable protocol which was in agreement with standard
practices in physiological journals, applicable to patient populations, and allowed
for optimal use of our NIRS spectroscopy[13, 18, 54, 61, 83, 84, 97].
Using a concurrent strain gauge measurement, we cross-validated our absolute
BF calibration by the optical technique during repeated VOs, finding correlation
between the two measurements of baseline BF. Healthy control subjects
produced hemodynamic profiles during exercise which agreed with those in
literature and against which we can compare future vascular/muscle disease
studies[13,17,54,55,83].
Lastly, a pilot study was performed to explore the feasibility of using the
calibrated hybrid spectroscopy and gated exercise protocol methodology for PAD
patient studies. The small population size, as mentioned previously, limits the
amount of empirical conclusion that may be made based on this data but results
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were promising. The measurement methodology proved no more difficult to
apply to patients than to healthy subjects and did not incur any medical risks
towards the patients. One flaw in the calibration protocol was that the arterial
occlusion (but not venous) was unable to apply sufficient pressure, or such
pressures induced pain and could not be applied, such that baseline absolute V̇O2
could not be calibrated and only the relative change in this parameter could be
observed during exercise. Subsequent research by other lab members applied a
similar method of calibrating both flow and oxygen consumption parameters with
venous occlusions that remedies this shortcoming[94, 95].
Exercise protocols produced continuous hemodynamic/metabolic profiles for
both healthy control and patient groups and the results thereof indicate a
promising line of research for investigation of PAD effects on muscle tissue. By
making use of the noninvasiveness, rapid sampling time, and continuous
collection properties of hybrid diffuse optical flow-oximetry in muscle tissue
during exercise the ability of the muscle to adapt/respond to metabolic stress can
be assessed for long periods of time and during dynamic protocols. Application of
these methods to future full-scale studies is likely to produce a unique
investigation of muscle physiology and disease pathophysiology, but many more
patients and healthy control subjects will be required to reach statistical and
diagnostic relevance.
In conclusion, the overall objectives of this research were successfully met in
that we were able to refine our measurement stability for contact probe DCSImagent hybrid spectroscopy on in-vivo muscle tissue and to extend the range of
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calibrated, standard unit, absolute measurements to the lower limb musculature.
We then obtained a consistent set of healthy control subject exercise responses,
for a variety of measured parameters (and subsequent derived parameters), which
could be used to monitor tissue hemodynamics/metabolic response to exercise
stress. Using such measurements as a basis of comparison, the initial steps were
taken to begin investigation of muscular disease states and their effects on muscle
tissue microvascular hemodynamics and metabolism at rest and during exercise.
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Appendix

Notes on Strain Gauge Plethysmography
Strain gauge plethysmography has many documented faults as an approach to
dynamic measurements since it can be greatly affected by fluid shifts typical of
working limbs (bone flow, interstitial fluids etc.) but this group found that more
than these theoretical flaws, implementing the strain gauge was difficult during
exercise due to the need to precisely apply a low pressure to the limb to get a
venous occlusion. Despite limiting the movement of the limbs complete lack of
motion is impossible and even small motions can loosen the pressure cuff (which
must be applied so as to not induce enough passive pressure to cause baseline
shift). This means that achieving venous occlusion without disturbing the
hemodynamics of the limb is difficult at best (and may explain the underestimate
of our venous occlusion values) if done properly.
Reasons for the possible underestimates in our strain gauge data are not
certainly known but are suspected to lay elsewhere than the strain gauge itself and
the recorded data as the sensitivity of the strain gauge to volume changes was
very high and the variability between individual BF measurements during
calibration quite low (mean standard deviation of 0.086). Pressure considerations
being what they were, we erred on the side of conservatism in applying the cuff
and this could have produced incomplete venous occlusions which (due to rapid
changes in hemoglobin post exercise) would be difficult to confirm using local
NIRS measurements. Post exercise VO can be observed in some subjects NIRS
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data via data frame time stamps (as in Figure 27) but were not observable in
enough cases to be correlated, and cannot be verified with the strain gauge itself.
Literature reporting resting muscle blood flows as low as 0.9 to 1.1 ml/100ml
tissue/min and as high 5 as have been observed using strain gauge
plethysmography[98]. The large degree of variability in blood flows reported in
literature from one study to the next suggests that there is a methodological or
equipment induced variation between groups that introduces substantial difference
in observed blood flow despite the procedure for strain gauge plethysmography
being tested and accepted as reliable and individual groups reporting low variance
within their respective studies. Given that our blood flow values are within
physiologically accepted ranges for resting blood flow and ranges reported by
other groups we may assume that our strain gauge data are reliable at rest.
Overall, strain gauge venous plethysmography can be considered a useful tool to
assess blood flow in resting conditions but is, in this author’s experience, not
trustworthy in dynamic measurements or for patient populations including
elevated blood pressure conditions, which encompasses the PAD patient
population, due to the increased mean pressures and often sclerotic vessels
making occlusions very difficult to reliably achieve, without applying pressures in
excess of those known to restrict vessel diameters[27].
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